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Abstract
Hemostasis is a complex physiological mechanism that functions to maintain
vascular integrity under any conditions. Its primary components are blood
platelets and a coagulation network that interact to form the hemostatic plug,
a combination of cell aggregate and gelatinous fibrin clot that stops bleeding
upon vascular injury. Disorders of hemostasis result in bleeding or thrombosis,
and are the major immediate cause of mortality and morbidity in the world.
Regulation of hemostasis and thrombosis is immensely complex, as it depends
on blood cell adhesion and mechanics, hydrodynamics and mass transport of
various species, huge signal transduction networks in platelets, as well as spa-
tiotemporal regulation of the blood coagulation network. Mathematical and
computational modelling has been increasingly used to gain insight into this
complexity over the last 30 years, but the limitations of the existing models
remain profound. Here we review state-of-the-art-methods for computational
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modelling of thrombosis with the specific focus on the analysis of unresolved
challenges. They include: a) fundamental issues related to physics of platelet
aggregates and fibrin gels; b) computational challenges and limitations for solu-
tion of the models that combine cell adhesion, hydrodynamics and chemistry; c)
biological mysteries and unknown parameters of processes; d) biophysical com-
plexities of the spatiotemporal networks’ regulation. Both relatively classical
approaches and innovative computational techniques for their solution are con-
sidered; the subjects discussed with relation to thrombosis modelling include
coarse-graining, continuum versus particle-based modelling, multiscale models,
hybrid models, parameter estimation and others. Fundamental understand-
ing gained from theoretical models are highlighted and a description of future
prospects in the field and the nearest possible aims are given.
Keywords: arterial thrombosis, thrombin generation, computational systems
biology, mathematical modelling
1. Introduction
Following injury, excessive blood loss is prevented by activation of hemostatic
mechanisms that cause the blood to clot and platelets to aggregate, physiolog-
ical processes that perform vital protective roles. These systems can also be
activated inappropriately, particularly as a result of vascular disease, leading5
to blood clot formation within the circulation, a dangerous thrombosis scenario
that is the key trigger for heart attacks and strokes. The field of thrombo-
sis and hemostasis represents a very special example of physical and chemi-
cal complexity of a living system, both because of its research challenges and
(patho)physiological importance.10
In order to maintain vascular integrity and stop blood loss, the systems
of hemostasis are exquisitely complex. They incorporate two interdependent
mechanisms, one mediated by blood cells known as platelets, and the second
complex biochemical cascades that result in the conversion of blood from a liq-
uid to a solid clot (coagulation). Platelet function encompasses processes of hy-15
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dromechanics, cell adhesion and shape change, muscle-like platelet contraction,
fluid-gel transformations together with intricate complexity of both intra- and
extra-cellular biochemical reaction networks possessing complex spatiotemporal
response dynamics. Coagulation is triggered by biochemical cascades involving
numerous catalytic steps that culminate in the conversion of soluble fibrinogen20
into insoluble and polymerized fibrin. These processes influence each other, with
coagulation pathways activated on the surface of activated platelets, and coagu-
lation enzymes also activating platelets. Recent decades witnessed an explosive
expansion of knowledge about this system, and yet its regulation (and even more
deregulation) remains poorly understood. As a visible proof of our insufficient25
understanding, that disorders of hemostasis remain the leading immediate cause
of death in the world. Various hemorrhagic and thrombotic complications are
associated with numerous conditions ranging from sepsis to cancer, from stroke
to myocardial infarction, from pregnancy to trauma, and play central roles in
their pathophysiological development.30
By definition, the way to understanding something complex is modelling,
be it experimental, computational or mental models. Indeed, mathematical
and computer models have been increasingly applied to solve biological prob-
lems in recent years. There has been an explosion in the number of papers on
“biomedical mathematical modelling”, “computational systems biology”, “vir-35
tual cell”, “virtual human”, “pharmacokinetic/pharmacodynamic models” and
similar subjects. These papers abound with seductive phrases like “comprehen-
sive model”, “multiscale model”, “fully three-dimensional model”, etc. Com-
putational biology is becoming immensely popular, although the majority of
experimental biologists and medical doctors are still cautious and insufficiently40
familiar or comfortable with its use. In particular note, however, there has been
considerable recent interest in the use of computational approaches to study
thrombosis and hemostasis and an increase in the numbers, complexity and
utility of associated computational models [1].
While computational studies provide important insights into different as-45
pects of hemostasis and thrombosis, it is essential to understand that there are
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presently no models of these processes that could be described as comprehen-
sive. The most successful models either focus on some aspects of hemostasis (e.g.
blood coagulation in vitro or platelet adhesion), or use simplified laws to grasp
general system dynamics. On the one hand, there are quite a few biological,50
physical or chemical things that we do not know about platelets [2, 3, 4], their
formation into aggregates (thrombi) [5, 6] at sites of injury, or coagulation [7, 8].
At the same time, there are physical and mathematical constraints that make
these models very hard to compute even when we do know the systems [9, 10].
For example, while 3-dimensional detailed models of adhering deformable blood55
cells are known, it would usually take weeks of supercomputer time to sim-
ulate several real-life seconds of platelet adhesion with a handful of platelets
and red blood cells involved. As a result, models of thrombosis itself are rarely
used in medicine or pharmacology. Testable predictions and fundamental hy-
potheses about thrombi are generated using simpler models [11, 10, 12], while60
mechanism-driven molecular-level insights are generated using models of signal
transduction [13, 14, 15] or blood coagulation in vitro [1, 16], and not complex
physiology-level models (with few exceptions) [17].
Why is it so? This review aims to answer this question, we shall discuss
not successes but rather obstacles in the developing models of hemostasis and65
thrombosis. While we shall pay attention to progress in the field and to the
promising developments (which are really exciting), the main focus will be the
problems that should be overcome to develop models of thrombus formation for
basic research and to aid clinical applications.
1.1. Hemostasis and arterial thrombosis: from physics to physiology70
The state-of-the-art picture of a blood clot formation could be simplistically
described as follows. Initially, right after injuring, the platelets adhere from the
bloodstream to the injury forming a brickwork-like aggregate. At the same time,
the plasma coagulates to produce fibrin and stiffen this aggregate. Thus a plug
forms to prevent the blood leakage through the injury. There is a conventional75
terminological difference between two principal situations. If the blood clotting
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takes place near an open wound or a hole in a blood vessel, then the process
is called “hemostasis”. It is a positive, protective phenomenon. Yet sometimes
the plug can grow inside a one-piece leakproof vessel due to numerous possible
reasons (from inflammation to atherosclerotic plug rupture) - then it is referred80
to as “thrombosis”. Both are thought to be the two sides of one coin.
In order to discuss challenges in the modelling of arterial thrombosis and
hemostasis, we need first to describe its primary aspects, these are summarized
in Fig. 1. There are two major physical mechanisms that stop bleeding upon
vascular injury: platelet aggregation and fibrin clot formation. Platelets are85
specialized blood cells capable of adhering to the site of vascular damage and
forming a plug to physically seal the wound. Fibrinogen is a protein present in
blood at a substantial concentration (about 0.5 % w/v) and converted by ac-
tion of thrombin into form fibrin following activation of the coagulation systems,
which can form a three-dimensional network of fibers, which results in a local90
gel formation, thereby forming a physical clot. The critical steps in hemostasis
and arterial thrombosis are shared, and this causes complications in the design
of medications that are able to suppress thrombosis without adversely affecting
hemostasis. Some reports do suggest processes, molecules or regulatory path-
ways whose effects are confined to hemostasis or thrombosis, whether these can95
be translated into safer therapies remain to be established, and consequently
most anti-platelet and anti-coagulant drugs are associated with bleeding side
effects. Amongst the complex and intertwined mechanisms of hemostasis and
thrombosis, computational modelling holds the potential to better understand
underlying mechanisms of action, and identify safer and more effective thera-100
peutic targets.
The first critical step in the formation of either hemostatic plug or arterial
thrombus is initial adhesion of platelets to collagen exposed at the site of vas-
cular damage. In order to do this, platelets should come in contact with this
collagen, and it is believed that interaction with red blood cells and red-blood-105
cell-mediated marginalization of platelets in the vessel [18, 19] are critically
important for this [20, 21]. Therefore, the efficiency of platelet attachment is
5
greatly dependent on rheology and the presence of erythrocytes [22]. Develop-
ing the correct micro-mechanical description of deformable cells in blood flow is
therefore the first challenge for any model of thrombus formation.110
Initial platelet adhesion in the arterial circulation is mediated by von Wille-
brand factor (vWf), a large multimeric molecule with unusual mechanical prop-
erties. Its conformation and adhesion efficiency are regulated by flow (by both
shear rate and elongation velocity), and their correct description is another
critical element of any thrombosis/hemostasis model.115
This initial vWf-dependent adhesion is relatively weak, so the next steps
of the platelet thrombus development depend on platelet activation. This step
has several layers of complexity. The effects of various agonists (beginning
with collagen itself) and antagonists are integrated by tens of platelet receptors
initiating several intracellular signalling cascades in a decision-making task of120
immense complexity [14, 15, 23]. As a result of this huge reaction network
action, platelets undergo transition to various activation states, associated with
a hierarchy of responses. These include improved adhesion and aggregation,
secretion or release of a plethora of auto/para-crine platelet activators into the
vicinity, externalization of phosphatidylserine to promote membrane-dependent125
reactions of coagulation, and thrombus contraction to stabilize and consolidate
the clot.
An important phenomenon that occurs side by side with thrombus formation
is a change in blood flow caused by partial or complete occlusion [11]. This can
have critical effects on thrombus growth and stability. Intra-thrombus transport130
processes including hindered diffusion and filtration may also be critical for
spatial control of several stages of thrombosis [24]. However, the most important
and straightforward effect is that “protection” of platelet aggregate makes it
possible for blood coagulation reactions to develop within the developing platelet
thrombus. Without such protection, blood coagulation and fibrin clot formation135
cannot function in the flowing blood [25]: there seems to be a threshold-like
regulation of coagulation by flow.
Fibrin formation is controlled by the blood coagulation network including
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about 50 proteins and co-factors interacting with each other as well as with
blood and vascular cells. The core of this network is a cascade of proteolytic140
reactions with numerous positive and negative feedback loops. This cascade
is a subject to complex spatiotemporal regulation, many elements of which
are still unclear [26]. Fibrin allows solidification of hemostatic plugs or of the
arterial thrombus. There are various interactions between blood coagulation
and platelet-dependent hemostasis: for example, thrombin (the main enzyme of145
coagulation) is a major platelet activator.
Finally, there is the problem of limiting thrombus formation. Normally,
after the thrombus was formed it stops its spatial propagation and is localized
near the damaged site, so that the blood circulation can further take place in
the organism. The physical and biological mechanisms behind this stoppage150
of thrombosis are not completely clarified (see Sections 3-5). As of now, there
are numerous hypotheses about this [11, 10, 12, 27, 28] but there is less known
about this than any other stage of platelet thrombosis.
1.2. Biophysical and biochemical challenges for theory: things that we do not
know about thrombosis155
There is a long list of uncertainties with regard to thrombosis/hemostasis
mechanisms. Although some of them can be circumvented theoretically (e.g.
by using phenomenological models), they remain a general impediment to the
development of efficient models.
We dare to speculate that the mechanics of platelet-RBC interaction do not160
represent such a problem. The challenges in their correct representation are
more computational as will be discussed in the respective section.
VWf action and interaction with platelets and collagen (or other substrates)
is, however, different. While there is some understanding of its mechanics, it is
far from complete. The ability of this protein to interact with different platelet165
receptors, its ability to be influenced by flow conditions, combined with its
ability to support platelet aggregates make it interesting and difficult to model.
The stages of platelet aggregate formation and blood coagulation are even
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Figure 1: Schematic representation of blood coagulation process. Blood flow with erythrocytes
and platelets (upper left, reprinted with permission from [19] ) and platelet with its role in
clotting (upper right). Coagulation cascade (lower image).
more puzzling. Here is a brief list of subjects that remain open and challenging
in the field. It should be clearly emphasized though, that these open subject170
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are not exactly obstacles for theoretical research, but rather opportunities to
apply computational methods for the solution of interesting problems. They
are, however, obstacles for medical applications of computer models because
a model for clinical or pharmacological application should be relatively free of
such uncertainties.175
1. The role of the contact pathway in arterial thrombosis (but, supposedly,
not in hemostasis). The coagulation network (see Fig. 1) can be activated
in two ways. It can be initiated by contact of a protein, called factor
VIIa, with a cofactor, the transmembrane protein tissue factor, at a site
of vascular damage. This so-called extrinsic pathway is believed to be the180
main way of coagulation activation in hemostasis. Alternatively, there is
a protein called factor XII at top of the coagulation cascade that can be
self-activated via contact with foreign materials. This “contact pathway”
is the main way of clotting activation in vitro, but deficiency of factor
XII is not associated with bleeding tendency. The contact pathway was185
not a source of interest to researchers until this last decade, when it was
found to be potentially involved in arterial thrombosis [29]. This could be
one of those rare cases when a biochemical reaction plays different roles
in thrombosis and hemostasis, and we still do not know why.
2. The effects of platelet-derived polyphosphates and coagulation activation190
by platelets. A related issue is the ability of platelets to not only acceler-
ate coagulation reactions but even initiate coagulation. This supposedly
occurs via release of polyphosphate from dense granules and contact path-
way [30], though there is evidence by different groups, including ours, that
other mechanisms could be involved [31].195
3. The functions of procoagulant platelets. One of the most mysterious ques-
tions in the field is why activated platelets form at least two subtypes: “ag-
gregating” platelets that can actually form the body of a hemostatic plug
or thrombus and procoagulant platelets that can accelerate reactions of
blood coagulation [32, 33, 34, 6]. As of now, there is a lot of information200
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about signalling pathways leading to these platelet subpopulations and
their properties, but no real idea about their physiological or pathological
significance.
4. The role of neutrophils in platelet adhesion during thrombus formation. A
role of other blood cells types, most notably neutrophils, in formation of205
various types of thrombi is being increasingly recognized. They are likely
to contribute both mechanically (in the adhesion) and biochemically, and
this is one of the subject that is lacking in all the existing computational
models.
5. Cell-derived microparticles and their numerous roles. Another component210
of blood with interesting and unclear abilities are cell-derived micropar-
ticles. These lipid bubbles, ranging in size from tens of nanometers to
more than a micron, possess a number of hemostasis/thrombosis-related
activities including ability to both activate and propagate coagulation
[35, 36, 37]. These include the presence of adhesion receptors, tissue fac-215
tor, phosphatidylserine and others. Some microparticles are present in
circulation and are greatly increased in number in case of inflammation
or cancer, while others are produced during thrombus formation as a re-
sult of platelet activation. While they are recognized as a prothrombotic
marker, their roles in hemostasis and thrombosis are unclear.220
6. The unique mechanical properties of fibrin. Finally fibrin gels themselves,
neither really fluid nor solid, represent an interesting challenge for com-
puter modelling [38]. It is probably les important for arterial thrombosis
(mainly driven by platelet accumulation) but is critical for venous one.
1.3. Thrombin generation and spatiotemporal regulation of blood clotting: a225
problem in itself
The blood coagulation network as depicted in Fig. 1 is a very interesting
example of a biological network with well-known biochemistry but poorly un-
derstood regulation. Although the main reactions of blood coagulation were
discovered over 20 years ago and there have been many models of coagulation230
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published [39, 40, 41, 42, 43, 44] there remains no model that can be success-
fully used alongside experiments with it having to be individually tailored and
adjusted. This is in spite of some models being compared to experiments, e.g.
our own model [40] that has been employed for data analysis in a number of
studies [25, 39, 45, 46]).235
The term “thrombin generation” has two meanings: it describes both a)
formation of the main clotting enzyme thrombin during blood coagulation under
any conditions, and b) the so-called thrombin generation assay, where thrombin
concentration in plasma is determined as a function of time in vitro following
stimulation in a controlled setting [47, 48]. While any computer model of blood240
coagulation necessarily includes thrombin generation in the first meaning, here
we shall focus on the second one, because wide use of the thrombin generation
assay for basic research and clinical data necessitated development of computer
models for the data analysis and at the same time provided a lot of information
for model validation. The typical design of the assay includes use of 96-well245
plates, where samples of plasma are recalcified, supplemented with phospholipid,
tissue factor and a fluorogenic substrate cleavable by thrombin and able to
indicate thrombin concentration.
There are a number of interesting challenges that are specific for thrombin
generation.250
1. How the onset of coagulation is regulated? The physiological activator of
coagulation, tissue factor, is not inactivated by itself. However, once it
forms a complex with factor VIIa, it can be inhibited by TFPI (Tissue
Factor Pathway Inhibitor). This Kunitz-type inhibitor has a beautiful
negative feedback mode of action: one of its Kunitz domains can bind255
factor Xa (that is produced by VIIa in complex with TF), and then another
domain can bind the VIIa-TF complex. The problem is that this two-step
inhibitory mechanism can not describe experimental data of thrombin
generation, with and without TFPI [7]. There are hypotheses to explain
this discrepancy, but the truth is that we do not know how the first step260
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of coagulation is really regulated.
2. Background contact activation. All real-life experiments take place in
tubes, plate or other labware. As foreign surfaces, they activate coag-
ulation via the above-described contact pathway [49]. This contribution
depends on the experimental design, but in many cases can significantly265
affect the results unless a specific inhibitor, like corn trypsin inhibitor or
something else, is used [50]. Most clinical protocols of thrombin generation
involve significant contributions of contact activation.
3. Membrane-dependent reactions of blood coagulation. The majority of blood
coagulation reaction occur not in solution, but on the surface of mem-270
branes provided by platelets, endothelial or sub-endothelial cells. These
reactions harbor quite a number of surprises [33, 34, 51], and their de-
scription in the existing model is but a first-order approximation that is
applicable within a narrow range of conditions.
4. Other. There are a number of other problems that include factor XI275
activation by thrombin [52] (a record-breaking reaction with 5-order-of-
magnitude difference in the experimentally reported rates unless we count
those who do not believe it to occur at all), problems with protein S
(infamously irreproducibly active), and a number of recently discovered
reactions.280
Once again, it should be stressed that these mysteries do not prevent re-
searchers from developing models for the purposes of research. In contrast,
such models can be used to get insight into these problems. However, in order
for a model to be applied in clinical situations, it has first to be established in its
basic features, and this is what is made difficult by our insufficient knowledge.285
In the following sections we will discuss blood coagulation and clot growth
beginning with thrombin generation (Section 2). We will introduce spatial ef-
fects (Section 3), fluid motion (Section 4) and the influence of blood cells (Sec-
tions 5 and 6). Finally we conclude with perspectives and future challenges.
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2. Thrombin generation290
The primary function of the coagulation system is the termination of bleed-
ing caused by vessel wall damage. This is achieved by covering the injured site
with a fibrin clot that appears at the final stage of a complex proteolytic enzy-
matic cascade where activated clotting factors act as catalysts for activation of
others [53, 54]. The key enzyme of this coagulation cascade is thrombin (Figure295
1), it uniquely catalyses the conversion of fibrinogen to fibrin as well as playing
a crucial role in controlling the kinetics of clot formation [53, 55, 56]. Throm-
bin formation can be launched by tissue damage that ruptures the endothelium
exposing tissue factor to blood flow (this is called the extrinsic pathway), or
by contact with a foreign substance where activation of factor XII triggers ac-300
tivation of factor XI (this is called the intrinsic pathway) [54, 57, 58]. Both
pathways lead to the activation of factor X that contributes to the conversion of
prothrombin to thrombin [54]. Once thrombin concentration reaches a thresh-
old value, further prothrombin activation takes place due to positive feedback
loops within the coagulation cascade [54, 57, 40].305
There are numerous works devoted to modelling the coagulation cascade
under different simplifying assumptions, these are necessary since the complete
reaction scheme is complex and not completely known, especially if platelets
are involved. In vitro coagulation kinetics through the extrinsic pathway were
modelled in [59, 60, 61, 62, 63] and through the intrinsic pathway in [64, 65,310
66, 67]. All of these models exclude platelets, their influence being taken into
account in [68, 69, 70, 71]. In vivo coagulation kinetics is studied in [72, 73,
74, 75, 76, 77]. These models all vary in the number of reactions (from 12 to
93), concentrations (from 6 to 92) and parameters (from 16 to 48) included,
reflecting the simplifying assumptions underpinning their construction.315
The coagulation cascade is often characterized by thrombin generation curves
(TGC) that represent the variation in thrombin concentration over time. Typi-
cal TGCs in response to various concentrations of tissue factor (extrinsic path-
way) are shown in Figure 2. These are characterized by their lag time (beginning
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of fast growth), time to peak, maximal thrombin concentration, endogenous320
thrombin potential (ETP, the area under the curve) and start tail time (concen-
tration close to 0). These values depend on the initial concentrations of blood
factors and on the reaction rates. Increases in the initial concentration of tissue
factor decrease the lag time and time to peak but increase maximal thrombin
concentration while decreases in the concentration of blood proteins can lead to325
the opposite effect, as occurs in blood from haemophiliacs.
Figure 2: Asymptotic approximations (broken lines) are able to capture thrombin concentra-
tion growth and its decay (equations (1), [41]), these are shown against numerical simulations
of the full model [78] for various levels of stimulant (parameter k1a). The asymptotic anal-
ysis is also able to provide simple equations that express the key metrics used to describe
TGCs (time to peak, peak thrombin concentration and ETP) in terms of initial conditions
and reaction rates.
Thrombin generation is not a perfectly standardized assay: differences in
the protocol and in the equipment could produce a large range of discrepancies
between the laboratories [79, 80]. All the models cited above can fit individual
curves, given a proper choice of parameters, and TGCs can even be described330
by a simple combination of exponential functions with four parameters [81, 82].
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However, there are numerous difficulties with the justification of these results
and their clinical applications:
- Recent studies show that these models with their “original” values of pa-
rameters give results that are very different from clinical data on healthy and335
hemophilic subjects [83]. Calibration (fitting) of the parameters improve the
results but the errors remain large (mainly in the interval 30-50 % for the ETP
and 50-200 % for the maximal value).
- It is not clear whether theoretical models can be used to predict the depen-
dence of TGCs on the initial concentrations of blood factors. Analysis of results340
shows that the precision of the theoretical curves decreases when varying these
concentrations [84]. This question has a crucial importance for the treatment
of blood coagulation disorders and of various diseases that influence blood co-
agulation (cancer, HIV and so on).
- There are a large variety of models proposed, describing alternative experi-345
mental or clinical conditions, and it is not clear whether these are valid under
alternative conditions. More complete models (with more variables and pa-
rameters) are not necessarily more precise because of the uncertainty with the
parameters and individual variability.
The incorporation of thrombin generation into multiscale models350
of thrombus formation. The development of a multiscale model of thrombus
formation necessarily involves multiple molecular and cellular components that
bridge both length scales, that vary from nanometers through to centimeters
(i.e. size of a protein to the diameter of a blood vessel), and time scales that
vary from milliseconds through to hours (i.e. protein reactions through to vas-355
cular remodeling). The incorporation of the coagulation cascade and thrombin
generation into a model of thrombus formation can highlight the mathematical
and computational challenges in formulating and analysing models of such com-
plex and disparate systems. This involves the development of models at each
scale as well as their integration into a cohesive whole. The challenge is that360
if all the details of a model developed at a finer microscale (such as thrombin
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generation) are incorporated into a macroscale model (such as thrombus for-
mation) then the complexity, and alongside it the computational costs, become
problematic. To overcome this challenge it is necessary to reduce the complex-
ity at the finer scale while retaining the models important dominant behaviour,365
that can they be passed to the model at the coarser scale. One method that can
be used to bridge time and/or space scales in this manner is matched asymptotic
expansions. A demonstration of this is given in [41] where the complexity of the
extrinsic pathway described in the full model [78] (cf. Figure 1) is reduced to a
smaller approximation that captures the dominant reactions behind the growth370
and inhibition of thrombin:
dP
dt
=
f(C)P
P + k1
,
dT
dt
=
f(C)P
P + k1
− k2T , (1a)
dV5
dt
= k3T +
k4V10
k5 + P
− k6V5V10 , (1b)
dV10
dt
= k7e
−γt − k6V5V10 , dC
dt
= k6V5V10 , (1c)
where P is the concentration of prothrombin, T the concentration of throm-
bin, V5 and V10 are the concentrations of activated factors V and X, respec-
tively, C is the concentration of prothombinase complex, and f(C) = k9 + C −√
(k9 + C)2 − k10C. The term k7e−γt describes the activation of factor X at375
the damaged vessel wall.
This reduced system of equations 1 is able to provide an excellent substitute
for the full model, this is demonstrated in Figure 2. It correctly describes the key
TGC characteristics, such as peak thrombin concentration, in terms of initial
conditions and reaction rates.380
Figure 1 demonstrates how such reduced model obtained via the method
of matched asymptotic approximations may be used in a model of thrombus
formation, linking models defined on a variety of scales. On the finest scale we
have the coagulation cascade (Figure 1, lower image), where a complex network
of protein interactions contributes to thrombus formation through its promotion385
of fibrin formation and platelet responses. By utilising asymptotic techniques
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we can simplify the complexities of the coagulation cascade into a small number
of equations or parameters, determining the response under different conditions
that can then be incorporated into the next scale (i.e. Figure 1, upper left)
where platelets aggregate into a growing thrombus.390
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3. Coagulation in quiescent plasma with space distribution
Having investigated the coagulation cascade utilising ordinary differential
equations we now increase complexity by taking into account the diffusion of
blood factors in plasma. The resulting reaction-diffusion system describe clot
growth and emits travelling wave solutions. The concept of clot growth as a395
reaction-diffusion wave was introduced in the 1990s [85, 81, 66] starting an in-
tensive investigation of wave dynamics and properties [82, 86, 87, 88, 89]. The
main questions here are the determination of the conditions of wave initiation,
the speed of its propagation and the mechanisms of its arrest. From a physi-
ological point of view these determine the clot’s size and differentiate normal,400
hemophilic and thrombotic plasma. In particular, low wave speed is specific for
hemophilic patients while large wave speed can result in thrombosis.
In this section we present new methods for the investigation of the reaction-
diffusion waves of blood coagulation allowing for the determination of the con-
ditions of its initiation and its arrest, as well as the speed of clot propagation.405
3.1. Clot growth as a reaction-diffusion wave
Self-sustained propagation of thrombin in plasma proceeds with constant
speed and can be considered as traveling wave solutions of the reaction-diffusion
system of equations describing the coagulation cascade:
∂u
∂t
= D
∂2u
∂x2
+ F (u), (2)
where u is the vector of concentrations of blood factors, D is the diagonal410
matrix of diffusion coefficient, and F (u) is the vector of reaction rates. Under
some simplifying assumptions the full system can be reduced to the system of
six equations for the concentrations V5, V8, V9, V10, V11 and T of active forms
of the factors V, VIII, XI, IX and X, respectively, and thrombin [66, 85, 81].
Then u = (V5, V8, V9, V10, V11, T ). This system of equations should be completed415
by equations for fibrin production from fibrinogen (activated by thrombin) and
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fibrin polymer production. Since these equations do not influence thrombin
production, system (2) can be considered independently.
Under the assumption of detailed equilibrium (large reaction constants) this
system can be reduced to a single equation for the dimensionless thrombin420
concentration θ:
∂θ
∂t
= d
∂2θ
∂x2
+ αθ3(1− θ)− σθ. (3)
The second term in the right-hand side of this equation describes thrombin
production and the last term its deactivation by antithrombin, σ is proportional
to the concentration of antithrombin.
Existence and stability of waves. It can be easily verified that the nonlinearity425
in equation (3) has three zeros if σ is less than some critical value. Furthermore,
the intermediate zero is unstable while the two others are stable. If σ exceeds the
critical value, then there is only one equilibrium σ = 0, and the concentration of
thrombin will necessarily vanish. Therefore, the bistable case with three zeros
is biologically relevant. It is proved that the vector-function F (u) in (2) has the430
same number of zeros as the scalar equation, u+ = 0, u0, and u−. The matrices
F ′(u±) have all eigenvalues in the left-half plane, and the matrix F ′(u0) has
a positive eigenvalue [90], [91]. In this case the thrombin free equilibrium u+
is stable. Coagulation begins if initial thrombin concentration exceed some
threshold level.435
Let us note that the vector-function F (u) satisfies the following condition:
∂Fi
∂uj
≥ 0, i, j = 1, ..., 6, i 6= j. (4)
Therefore, if we consider system (2) on the whole axis it has a travelling wave
solution u(x, t) = w(x − ct) [90, 91, 92, 93]. Here c is the wave speed, and the
function w(x) satisfies the equation
Dw′′ + cw′ + F (w) = 0, w(±∞) = u±. (5)
This wave is unique up to translation in space and globally asymptotically stable
in the following sense. Consider system (2) with initial conditions u(x, 0) =
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u0(x) such that it is a monotonically decreasing (component-wise) function with
the limits u0(±∞) = u±. Then the solution converges to the wave, u(x, t) →
w(x− ct) as t→∞.440
Convergence to the wave may not hold if the initial condition u0(x) is not a
monotone function. As is usually the case for bistable reaction-diffusion systems,
it should exceed some threshold. System (2) has a stationary pulse solution,
that is a positive stationary solution w0(x) with the zero limits at infinity [94],
[95]. Moreover, such solution exists if and only if the wave speed is positive.445
If u0(x) > w0(x) for all x, then the solution grows and converges to the wave.
If u0(x) < w0(x) for all x, then the solution decays and vanishes. Thus, the
pulse solution determines the initial thrombin concentration that provides clot
growth.
Thus, we obtain two conditions for clot growth. The first is the condition450
on the parameters which provide the positiveness of the wave speed. This con-
dition is equivalent to the existence of the pulse solution. The second condition
concerns the initial thrombin concentration. It should exceed the pulse solution.
Hence there is a need to determine the wave speed and the conditions of wave
initiation.455
Speed of propagation. The wave speed c for system (2) converges to the speed c0
for the single equation (3) in the limit of large reaction rate constants [90, 91].
The speed c0 for the single equation can be approximated by the narrow reaction
zone method and by a piecewise linear approximation [91]. They give a good
approximation for the speed of the complete system and of the experimental460
results (Figure 3).
Initiation. Initiation of clot growth occurs at the injured vessel wall, due to the
expression of tissue factor which forms a complex with factor VIIa (activated
factor VII) subsequently activating factors IX and X, that are present in plasma.
These factors promote the conversion of prothrombin into thrombin. Taking the465
initiation into account, instead of a simplified one-equation model (3) we obtain
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Figure 3: Left: speed of the thrombin wave propagation (mm/min) as a function of percent-
age of factor IX activity. Dots: experimental data [88]; dashed line: narrow reaction zone
approximation; dash-dot line: piecewise linear approximation. Right: thrombin distribution
at the consecutive moments of time for the complete model (a) and for the single equation (3)
(b). Thrombin profile becomes monotone for the one-equation model because the equation
for prothrombin is eliminated. Despite this difference, the speeds of propagation remain close.
Reprinted with permission from [91].
the equation
∂θ
∂t
= d
∂2θ
∂x2
+
(
βe−rx + αθ3
)
(1− θ)− σθ, (6)
where the term βe−rx describes the initiation by the wall located at x = 0. If
β = 0, it is reduced to equation (3).
Similar to system (2), equation (3) considered on the whole axis has a pulse470
solution θ0(x), that is a positive solution with zero limits at infinity. If the initial
condition for equation (3) is greater than the pulse solution, then the solution
of this equation converges to the wave, if the initial condition is less than θ0(x),
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then the solution decays and converges to zero. The former corresponds to clot
growth, while the latter to its failure. If the quantity of thrombin produced at475
the initiation stage (α = 0) is greater than the threshold determined by the
pulse solution θ0(x) (for x > 0), then the clot will grow. Otherwise, there will
be some limited quantity of thrombin produced near the wall without further
clot growth.
3.2. 2D growth and arrest480
Blood coagulation is inhibited via TFPI (tissue factor pathway inhibitor)
present at the surface of endothelial cells, antithrombin, which is present in
blood plasma, and protein C, that is activated at the intact surface by a complex
of thrombin and thrombomodulin and then diffuses in the vessel lumen. The
concentration of antithrombin should be sufficiently low in order to allow the485
initiation and propagation of the thrombin wave. TFPI regulates the activation
of the coagulation cascade at the vessel wall. Once propagation commences,
neither of them (antithrombin, TFPI) cannot stop it. It can be verified that in
the 1D model activated protein C does not stop the wave propagation neither.
Therefore, in order to describe clot growth arrest via activated protein C we490
need to consider 2D or 3D formulations, with an injured part of the wall where
thrombin production is initiated and an intact part of the wall where protein
C is activated. Protein C can then diffuse to the injured site and decelerate
thrombin production. There is competition between self-sustained thrombin
production and thrombin induced protein C activation, which downregulates495
thrombin production. For fixed values of other parameters, the result of this
competition is determined by the injury size. If the injury size is sufficiently
small, then the diffusion of activated protein C to the damaged site will be large
enough to arrest thrombin production. If the injury is sufficiently large, then
protein C does not stop wave propagation (Figure 4).500
Thus, there are three regimes of clot growth in quiescent plasma: initiation
without propagation, initiation with propagation and with growth arrest and
initiation with propagation without growth arrest [96]. The clot growth arrest
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Figure 4: A snapshot of thrombin concentration, fibrin polymer and activated protein C.
Thrombin production is initiated at the injury site (center of lower boundary) and diffuses
to the intact wall to form a complex with thrombomodulin, activating protein C. The latter
diffuses back to the injury site and downregulates thrombin production. However, activated
protein C is not sufficient here to fully arrest thrombin production and a thrombin wave
escapes to the region where activated protein C does not reach.
critically depends on the lesion size with a sharp transition between complete
and partial occlusion [97].505
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4. Coagulation in flow without blood cells
Increasing the complexity of the model we now introduce blood flow, ex-
cluding the influence of blood cells, which will be considered in the following
sections. Blood flow brings inactive blood factors, such as prothrombin or fib-
rinogen to the clot and removes active factors, including thrombin, from the510
clot. Conditions of clot initiation in flow and the distributions of blood fac-
tors during clot growth are studied in several works [98, 99, 100, 101, 102] and
include comparisons with experiments undertaken in flow chambers [103, 104].
Coagulation with non-Newtonian flow is studied in [105, 106, 107].
Clearly, flow can affect the initiation of clot growth, both its speed and size.515
In the previous section we discussed the mechanism of clot growth arrest by
means of activated protein C. We showed that if the damaged area of the blood
vessel wall is sufficiently large then clot growth cannot be stopped, resulting in
the complete vessel occlusion. Blood flow removes thrombin from the injured
site and it represents an additional factor that can stop clot growth. Its influence520
is felt more dominant far from the vessel wall, where the flow velocity is larger
and where the action of activated protein C is weaker.
A growing clot changes the geometry of blood flow and increases the com-
plexity of the model. A possible approach to this problem is to consider it as
a free boundary problem where the interface between the blood and the clot525
moves with time. In this case we need to trace this interface at every time step,
solving Navier-Stokes equations in a complex domain with variable geometry.
The interaction of blood flow with clot can be taken into account through
the addition of terms to the Navier-Stokes equations which describe flow decel-
eration inside fibrin mesh:
ρ
(
∂−→v
∂t
+−→v · ∇−→v
)
= −∇p+ µ∆−→v − µK(Fp)−→v , (7)
∇−→v = 0, (8)
where K(Fp) = cF
1.5
p (1 + 56F
3
p ), Fp is the concentration of fibrin polymer and
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Figure 5: Snapshots of thrombin distribution (left) and fibrin distribution (right) in the be-
ginning of clot growth (upper row) and before complete occlusion (lower row). Reprinted from
[97] with permission.
c is a numerical factor depending on the properties of fibrin mesh [108]. The
advantage of this method is that the equations of fluid motion can be solved in530
the whole domain and do not need to determine the clot shape.
In order to describe the influence of blood flow on the growing clot, consider
the rectangular domain 0 ≤ x1 ≤ L, 0 ≤ x2 ≤ H with no-slip boundary
conditions at the lower and upper boundaries x2 = 0, H. In the case of the
given velocity field at the left and right boundaries x1 = 0, L, it can be the535
parabolic flow: v1(x2) = ax2(H − x2), v2(x2) = 0 with some given constant
a. This boundary condition is convenient for small clots which do not strongly
perturb blood flow. However in the case of large clots and, even more, in the
case of complete occlusion, it will lead to unrealistic flow behavior. Indeed, if
we take as an example the case where fluid cannot penetrate the clot (large540
K(Fp)), then mass conservation results in unbounded flow velocity as the clot
approaches complete occlusion. To get a more realistic description of blood flow
for large clots, instead of flow velocity the pressure difference is imposed. This
means that the constant a in the parabolic profile is not given, it is dependent on
time and is chosen in such a way that the difference between the mean pressure545
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at x = 0 and at x = L is a given constant. In particular, a can decrease in the
process of clot growth, and can vanish in the case of complete occlusion and an
impenetrable clot.
Figure 6: The final height of the clot in the case of different values of the initial blood
flow velocity. Left: numerical simulations for different values of antithrombin concentration
A in plasma. Right: numerical (solid line) and analytical (dashed line) solutions of the
simplified model for A = 0.4. For both models, complete occlusion occurs for low flow velocities
and partial occlusion for high velocities with a sharp transition between these two regimes.
Reprinted from [109] with permission.
Equations for the concentrations of blood factors now contain convective
terms. Examples of numerical simulations of clot growth in flow are shown in550
Figure 5.
In order to obtain analytical estimates of clot growth, we consider the sim-
plified equation for thrombin concentration
∂θ
∂t
= D
∂2θ
∂x2
+ Φ(θ, x), (9)
where
Φ(θ, x) = αθ3(1− θ)− σ(x)θ,
σ(x) = σ0A+ σ1v1(x). This is similar to equation (3), with an additional term555
in σ(x). The first term in the expression for σ takes into account inhibition
by antithrombin, the second term describes the loss of thrombin due to blood
flow. Velocity profile v1(x) can be parabolic or it can take into account the
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influence of clot on flow velocity. For simplicity of notation we denote here by
x the variable x2 perpendicular to the injured vessel wall.560
Set I(x) =
∫ θ∗(x)
0
Φ(θ, x)dθ, where θ∗(x) is the largest zero of the function
Φ(θ, x) for fixed x. In the case without flow, where the function and the integral
do not depend on x, condition I > 0 provides the positiveness of the wave speed,
that is the condition of clot growth. Since the thrombin wave front is sufficiently
narrow, then a similar condition can be applied for every fixed x. Therefore,565
the thrombin wave propagates for the values of x where I(x) > 0. Condition
I(x) = 0 determines the maximal clot size if it less than H. Figure 6 shows the
maximal clot size as a function of the maximal flow velocity obtained in direct
numerical simulations of the 2D problem and in the approximate 1D equation
(9). The analytical condition through the sign of the integral and numerical570
solution of the simplified equation give a good approximation of the final clot
size and of the conditions of complete occlusion.
A similar combination of numerical simulations and analytical estimates is
used in [110] to study thrombosis treatment with warfarin. The influence of
rheumatoid arthritis on thrombosis is investigated in [111].575
Thus, in addition to three regimes of clot growth in quiescent plasma, there
are two different possibilities depending on blood flow. In the case of propaga-
tion without arrest by activated protein C, blood flow can stop clot growth or
clot growth can continue leading to the complete occlusion.
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5. Role of blood cells: Platelets580
Although models of plasma coagulation are important for understanding
hemostatis mechanisms in veins and in vitro, the basis of arterial thrombosis
is the attachment of blood platelets to the vessel wall injury [112, 113, 114].
Platelets are the principal components of the hemostatic plug formed to ar-
rest bleeding after an injury to the vascular wall. The most prominent of the585
hemostatic disorders is the thrombosis manifested by intravascular formation
of platelet-fibrin clots that obstruct blood flow in the vessels. Attachment of
platelets and their accumulation into thrombus is regulated by mechanical in-
teractions with erythrocytes and vessel wall, by numerous chemical agents such
as thrombin, or ADP, or prostaglandins, or collagen, as well as by an enor-590
mous network of intracellular signalling. The complexity of platelet aggregation
and activation during thrombosis makes it an challenging goal for computa-
tional modelling: the problem involves complex hydrodynamics, cell adhesion
mechanics, chemical cascades and a variety of different interplays between these
phenomena [115], some of which are yet to be understood.595
5.1. Platelet adhesion and aggregation in flow
5.1.1. Continuum-based models
Blood platelets adhere to injured tissue to initiate the healing process in
primary haemostasis. The accurate analysis of platelet-vessel wall interaction,
their collisions and aggregation, and also their differentiation to subpopulations600
requires a resolution of individual cells, their motion and mechanics in 3D, that
is presently possible for a very little number of cells and very small volumes.
Therefore, thrombus formation on the large scale usually requires simplified
continuum models, based on PDEs. The main shortcomings of this approach
include poor small-scale accuracy and the need to include phenomenological me-605
chanical properties of a thrombus. However, these models allow analytical inves-
tigations of the thrombus formation principles, formulating the prediction and
observing the macroscopic morphological evolution of a thrombus over a long
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time-scale (up to several hours). The main problem here is the moving bound-
ary condition at the thrombus surface, where both computational efforts (re-610
meshing) and physical solutions (platelet adhesion, detachment rates, thrombus
mechanics, etc.) should meet. Therefore, the construction of a mathematical
model of the formation of a platelet aggregate with an adequate representation
of its physical, chemical, and biological processes is an extremely complicated
problem.615
In works by Fogelson et al. [101, 116] cells were tracked via their concentra-
tions ci the very same way as for the plasma coagulation factor. A system of
reaction-diffusion-convection equations has the following form:
∂ci
∂t
+ (u · ∇)ci = Di∆ci + Si(ci) (10)
Here Di are the diffusion coefficients, which for platelets may depend on local
hydrodynamic conditions (i.e. shear rate) [21, 117], and Si(ci) are the reaction
rates, representing here platelet activation, adhesion and aggregation. The mov-
ing boundary issue was resolved by domain decomposition approach, namely,
the introduction of a “reaction zone”, where all the cell-cell interactions, ac-620
tivation and binding take place, and advection zone (or bulk fluid), where no
interactions occur, and only the passive streaming exists. The specially defined
function of platelet inflow and outflow rates were used for fitting the concen-
trations on the boundary between zones. Advective and diffusive transport of
platelets into or out of the reaction zone occurs at a rate proportional to the625
difference in the platelet concentration in the bulk fluid and in the reaction
zone, and the value of a mass transfer coefficient. Platelets were considered to
be in one of three states: i) unactivated and unattached (freely moving with
the plasma), ii) activated and adherent to the subendotheleum, or iii) activated
and bound to other platelets in the thrombus. However, such chemical ago-630
nists as ADP and TxA2 (normally released by platelets) were not accounted
for explicitly in the model. Instead, the activation of platelets by contact with
other activated platelets was introduced as an artificial rule. Besides, there is
an experimental evidence that platelets can adhere to each other via GPIb-vWf
29
bonds in unactivated state [118]. The most strong assumption is that each635
chemical or platelet species were assumed to be well mixed (and homogeneous)
in the reaction zone, which may not be the case in general. Whence this study
is based upon approximations reasonable for small spatial domains and small
thrombi, the models of large and occlusive thrombi (where inhomogeneities are
important) will require a different approach.640
In [119] the specific growth model defines the plug interface displacement
based on the outcome of the biochemical model, that is, on the number of
deposited bounded platelets on the injured part of the vessel wall. A system of
reaction-diffusion-convection equations all coupled to each other was introduced
to describe the evolution of concentration fields of all the species - proteins,645
solvable agonists and platelets, similar to [116]. However, the growing boundary
of the thrombus was treated by Robin boundary condition that imposed a flux
on the surface of thrombus/injury. It should be noted here that rules, upon
which platelets attach to each other are different in [116] and [119], identifying
the fact that the understanding of interactions and signalling between platelets650
in different states should be clarified by the means of detailed cell-based models
and experimental work.
The most typical feature of early continuous thrombus models is the non-
physiological growth of a thrombus against the flow direction. To avoid this,
deformations of the thrombus induced by the hydrodynamic drag should be
taken into account. A special model describing the adhesion of platelets in
terms of their concentration was constructed in terms of platelet concentration
[120]. It was assumed that the movement (rolling or sliding) of the already
adherent platelets due the flow is one of the key processes in the thrombus
formation. Specific terms accounting for thrombus deformation by the flow were
introduced phenomenologically in order to obtain the experimentally observed
shapes of thrombi in model (in 2D case):
∂C
∂t
= kadhγ˙
(
1− C
Cmax
)(
C
λ
+ |∇C|
)
− krol∇ · (vC) (11)
where Cmax is the maximum value of the platelet concentration (dense packing),
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γ˙ is the wall shear rate, kadh is the coefficient of platelet adhesion efficiency and
krol is the coefficient of platelet movability within a thrombus. It was assumed655
that the movement of platelets over the thrombus surface is one of the key
processes in the thrombus formation. The mathematical scheme was based on
solving together the PDEs for concentration with Navier-Stokes equation. The
shapes of thrombi obtained it that work depended strongly on the coefficient
krol. For krol = 0 the model resulted in non-realistic thrombi growing against660
the flow, while for krol ≈ 10−5 the streamline shapes were obtained. This
revealed the importance of thrombus deformability for the continuum modelling
of thrombosis.
In [121] a PDE-based model of a platelet aggregate formation has been pro-
posed, which used similar boundary-zone method for modelling platelet adhesion665
as in [116]. The authors replaced the boundary of the platelet aggregate by a
narrow transition zone, where the platelets carried by the flow are captured at
the specific rates. The distinction was that in [121] the platelet attachment rate
depended on shear rate and RBC concentration, taking into account implicitly
the promotive effect of RBCs on thrombus formation. Also, the activation from670
ADP was considered in a trigger manner according to the rule “all or nothing”:
low concentrations practically do not influence a platelet, but high ones cause
the complete activation in a finite time, in accordance with known experimen-
tal data. Recently, the idea of a shear-rate dependent platelet accumulation
rate was used in [11] to study effects of hydrodynamic forces and injury size675
on thrombus growth dynamics and occlusion. It was shown that the balance
between platelet adhesion rate and thrombus erosion caused by hydrodynamic
forces determines the effective thrombus growth rate keff , which depends on lo-
cal shear rate γ˙ at the surface of a thrombus. Together with hydraulic effects in
microcirculation system, which cause non-linear change in the shear rate during680
the narrowing of the lumen, this resulted in a threshold-like behavior of a grow-
ing thrombus. Depending on the size of injury, two distinct dynamic pathways
of thrombosis were found: the formation of a nonocclusive plug, if injury length
does not exceed the critical value, and the total occlusion of the vessel by the
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thrombus otherwise. Using only basic physical principles, not involving com-685
plex biochemical concepts, it was possibly to describe the switching mechanism
between occlusive and non-occlusive thrombi in microvasculature.
As we see, the usage of continuum-based models in thrombosis and hemosta-
sis has been fruitful, as it brought to life a number of ideas that encouraged
experimental studies. Despite all the limitations, it would be considered as690
a handy instrument for both theoretical research and practice (engineering).
However, some effects remained beyond the scope of continuum modelling of
thrombosis nowadays. For instance, the correct constituitive model for throm-
bus mechanical and rheological properties is still missing. Also the proper choice
of phenomenological constants is required. The internal structure of the throm-695
bus that might be important for understanding the mechanisms of thrombosis
regulation should be taken into account. Another issue that should be addressed
in further studies is whether the platelet activation is an instant event or a mul-
tistage process, and how the platelet activation pathway influences the stability,
density and final size of a thrombus.700
5.1.2. Effect of flow on platelet plug formation
When the plug height is significant with respect to the vessel diameter,
hydrodynamic forces play a crucial role in platelet thrombus growth. [119,
11]. The interplay between platelet adhesion forces and the flow influences
bounded platelets distribution, thrombus shape and the dynamics of the plug705
development. Let us consider here a simple model of platelet thrombus growth in
a microvessel, taking into account both the erosion of the thrombus by the flow
and the redistribution of the hydrodynamic velocities and pressure in circulatory
system caused by the plug formation. Consider a hydraulic circuit presented in
Fig.7.710
The heart acts as a pump providing a systole-averaged constant flow rate
Q0. Let the thrombotic vessel to be presented as a series of resistive elements: a
stenosed segment with resistance Rx(t) and a healthy segment Rh. Let there be
also a shunt consisting of a number of healthy vessels with overall resistance Rw.
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Figure 7: Hydraulic scheme of the thrombotic vessel (represented by “resistors” Rh and
Rx(t)) and the bypass Rw.
They provide bypass for blood flow as the thrombotic vessel is being occluded.
Let us also approximate the thrombus by a ring characterized by its length
l = const, and inner radius r(t). This is a rather strong assumption, but it
would let us couple the hydrodynamics and thrombus growth and would allow
the analytical consideration of the model. Therefore, one may simply write the
expressions for pressure, blood flow rates and shear rates using Hagen-Poiseuille
law Q ·R = ∆p and Kirchhoff’s circuit laws. The increase of thrombus volume
dV in time dt is caused by the inflow and adhesion of platelets through the
surface of the plug/reaction zone jinAdt, and the decrease of plug volume due
to drag −joutAdt is governed by the erosion rate jout ∝ γ˙ proportional to the
shear hydrodynamic forces exerted on the surface of a plug. The equation for
thrombus volume evolution reads
dV
dt
≈ (jin − jout)2pirl. (12)
Let for simplicity jin = const = k0 and jout = ξγ˙. Here V = pi(r
2
0− r2)l, so that
dV = −2pirldr. By introducing dimensionless values, we obtain the equation
for the lumen radius:
−dr
dt
= k0
(
1− γ˙
γ˙cr
)
, (13)
where wall shear rate γ˙ is found by solving the Kirchhoff equations for the
hydraulic circuit. Critical shear rate γ˙cr = k0/ξ corresponds to zero growth rate
of the plug.
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One can obtain a formal expression for the relation between the flow rate
Qx and the applied pressure difference ∆px using Hagen-Poiseuille law and
Kirchhoff circuit laws as follows:
Qx(t) =
Q0Rw
Rw +Rh +Rx(t)
. (14)
The pressure drop ∆px = p
in
x − poutx = Qx(t) ·Rx(t) is found to be:
∆px(t) =
Q0RwRx(t)
Rw +Rh +Rx(t)
. (15)
For an axisymmetric thrombus (when thrombus growths over the whole perime-
ter of vessel’s cross-section ) the lumen has a circular shape with inner radius
r(t) < r0, and the hydrodynamic problem may be solved exactly, so we find the
hydraulic resistance of the thrombotic region
Rx(t) =
8ηl
pir(t)4
, (16)
and the shear rate at surface of thrombus
γ˙ =
∆px · r(t)
2ηl
, (17)
where η is fluid viscosity. Since we do not consider RBCs in this example and
this chapter, Newtonian fluid η = const will be a good approximation.715
For convenience we introduce the following dimensionless values: the relative
thrombus length λ = l/L, scaled vessel’s radius ρ0 = r0/L, inner radius of the
lumen ρ = r/L, and τ = tk0/L is the dimensionless time. We define typical
scale for hydraulic resistance as:
[R] =
8η
piL3
. (18)
As for the flow rate scale, it is convenient to express this value through combina-
tion of blood flow rate at the outlet of the heart Q0 and the shunting hydraulic
resistance Rw: [Q] = Q0Rw/[R]. Pressure difference was thus scaled to a factor
[∆p] = Q0Rw. Shear rate in the stenosed vessel γ˙ was scaled to the initial shear
rate (when no thrombus yet grown)
γ˙0 =
[∆p]ρ0
2η
=
Q0Rwr0
2ηL
, (19)
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Figure 8: (a) Growth dynamics of axisymmetric thrombi for different thrombus lengths
(ρ0 = 0.25, k0 = 1.0, ξ = 0.25, Rw/[R] = 0.1). (b) Dimensionless growth rate (-ρ˙) as a
function of thrombus height for the same parameters.
so that dimensionless shear rate G = γ˙/γ˙0. The equation 13 in dimensionless
form reads
−ρ˙ = 1−G/Gcr (20)
with Gcr = γ˙cr/γ˙0 and
G =
γ˙
γ˙0
=
(ρ/ρ0)
λ+ (1− λ)(ρ/ρ0)4 + ρ4(Rw/[R]) , (21)
The thrombus growth dynamics is presented in figure 8. We see that depend-
ing on the relative length of an injury λ = l/L, the thrombus may stop growing
(if λ is small enough) or keep growing until total occlusion of the vessel. The
detailed analysis of the problem tells that the saddle-node bifurcation occurs
in the system when λ increases [11]. There exists a critical thrombus length
λcr that differentiates the regimes of occlusion and thrombosis stoppage. For
λ > λcr, the thrombus always blocks the vessel, while for λ < λcr the throm-
bus reaches finite size. The value λcr should be determined from the condition
Gmax = Gcr, where Gmax is the peak value of the dimensionless shear rate. This
value is found from the condition:
dG
dρ
= 0. (22)
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Thus we find the radius ρ∗, for which extremal shear rate Gmax is achieved:
ρ∗
ρ0
=
[
λ
3(1− λ) + 3ρ40(Rw/[R])
]1/4
, (23)
and
Gmax =
33/4
4λ3/4(1− λ+ ρ40Rw/[R])1/4
, if λ ≤ 3
4
(
1 + ρ40
Rw
[R]
)
, (24)
Gmax = 1, if
3
4
(
1 + ρ40
Rw
[R]
)
< λ < 1. (25)
Therefore, the formation of a stable finite thrombus in our model is possible for
λ < 0.75
(
1 + ρ40Rw/[R]
)
(otherwise thrombus growth is not possible at all due
to strong drag forces). And the condition Gmax = Gcr results in
λ3cr
(
1− λcr + ρ40
Rw
[R]
)
=
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256
(
1
Gcr
)4
. (26)
Here Gcr = (k0/ξ)/γ˙0 is the combination of biological (k0, ξ) and hydrodynamic
(γ˙0) characteristics that defines the evolution of the system. Basically, (k0/ξ) is
the ratio of platelet influx and drag-induced erosion. The solution of algebraic
equation (26) determines critical thrombus length λcr = lcr/L, so that if λ > λcr,
the thrombosis always proceeds to occlusion, and for λ < λcr the thrombus720
reaches stable non-occlusive size. A saddle-node bifurcation occurs at λ = λcr.
Usually, ρ40Rw/[R] 1 in microvasculature, so that this term may be neglected,
and the dynamics of the ring-shaped thrombus in our model is governed by Gcr
parameter and thrombus length λ.
The results of a simple model suggest that the mechanism of thrombosis regu-725
lation in microvasculature rests on the balance between the platelet-aggregation
rate k0 and hydrodynamics-induced wash-off of the platelets from the plug. The
principal conclusion is the existence of a threshold injury length demarcating
regimes of occlusive thrombosis and growth stoppage. Strictly, the plasticity
and deformability of a platelet aggregate escape from our scope in this consid-730
eration due to the model restrictions. Besides, length of the plug may change
during growth. However, this elongation is usually moderate (smaller than an
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order of magnitude) and is not essential for microvascular thrombi. We also
do not consider here a number of biological processes and features (platelet
activation, fibrin growth, granule secretion, extent of damage, tissue-factor con-735
centration, etc.) that take place inside the thrombus and basically cannot alter
the surface-related hydrodynamic mechanisms considered here. These processes
however may play an important role in biological regulation of thrombosis and
hemostasis and should be addressed in further research: rheology and elasticity
of a thrombus, vasoconstriction, platelet activation, platelet signaling inside the740
thrombus and plasma coagulation, etc.
Arterial walls are exposed to tangential shear stress and normal intraluminal
pressure. Mechanical stimuli may cause a myogenic response: the variations in
diameter of arteries or arterioles resulting from contraction and relaxation of
smooth muscle cells in their walls [122, 123, 124]. This phenomenon, known as745
vasomotion, could be modulated by pressure changes [125, 126], and it is indeed
the case during thrombosis and hemostasis. It is known that vasoconstriction
of damaged arteries is one of the protective mechanisms, that takes place in the
very first moments after the injury. It is particularly important in restraining
acute haemorrhage in arteries: the constriction of the vessel lumen lessens the750
blood flow rate. In microvessels the vasomotion also affects the dynamics of
thrombus growth in cases of a puncture-induced thrombosis (see for instance
[114] and supplemental video 1 therein). The mathematical modelling of this
phenomenon is a challenging task itself: both myogenic and metabolic autoregu-
lation should be coupled to mechanical model of vessel walls and hemodynamics.755
A number of continuum-based models of vasoconstriction exist [127, 125, 123]
and, hopefully, integration of this module into multiscale models of thrombosis
and hemostasis will be possible in near future.
5.1.3. Discrete models
Whereas continuous models describe macroscale dynamics of platelet con-760
centrations, it is reasonable to suggest that many aspects of thrombosis are
better modelled as discrete events at the microscale. Modelling explicitly the
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transport, activation, and adhesion of platelets is crucial for predicting thrombus
formation and growth following a thrombotic event in normal or pathological
conditions. Particle-based discrete models are used in a variety of problems deal-765
ing with biological complexity, however computational costs may be tremendous
in case of thrombosis as the number of cells in simulation may reach hundreds
of thousands or greater depending on the dimensions of the problem.
Discrete methods may be subdivided in two classes: 1) coarse-grained ap-
proaches and 2) high-resolution cell models. The first class treats cells as par-770
ticles interacting via a central potential and coupled to fluid usually via Stokes
friction force [117, 10, 128, 129]. It is possible to simulate the assembly of
tens of thousands to millions of cells or particles with reasonable computational
efforts. Although the details of cell shape, contact forces and adhesion are
simplified and sometimes neglected in coarse-grained approaches, one may still775
resolve the micro-structure of cell aggregates and emerging marcoscopic mate-
rial properties. The second class of methods provides more details by the cost
of computational complexity. Those models where platelets are represented as
material points/spheres with a central potential are conceptually different from
e.g. models accounting for each individual bond, cell shape and deformations,780
etc. [130, 131, 132, 133]. In the latter case the spacial resolution that is re-
quired/accessible scales as 10 nm, while for coarse-grained - as 1 micrometer.
Consequently, computational efforts required for high-resolution models. We
further discuss several examples of discrete models of platelet aggregation in
flow starting with coarse-grained models.785
A notable model was proposed by [134] with a stochastic cellular Potts model
(CPM) used to describe cell-cell interactions. The CPM is a cell-level, energy-
minimization-based lattice model, which uses an effective energy (Hamiltonian)
coupled with the local flow rate, to describe cell dynamics, adhesion, differenti-
ation, division and hapoptosis. Given an effective energy one can calculate the
resulting cell motion using Metropolis dynamics algorithm. Being the extension
of idea of lattice automata, just like Lattice Boltzmann scheme used extensively
nowadays to simulate viscous fluid flow in complex geometries [135], this scheme
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was developed for a number of biological problems including cell division, bac-
terial films [136], tissue growth, cell differentiation and others [137, 138]. The
trial of CPM in thrombosis and hemostasis simulations was almost inevitable. In
[134] it was assumed that activation of platelets occurs when the concentration
of chemical components is higher than a specified threshold. The effective acti-
vator concentration was calculated as function of the three main agents (ADP,
TxA2 and thrombin fIIa), accounting for the additive effect of the exceed of
their concentration above certain thresholds:
Ω =
[TxA2]
[TxA2]th
+
[ADP ]
[ADP ]th
+
[fIIa]
[fIIa]th
. (27)
Despite biological complexity of this model, the shapes of thrombi were far from
the experimentally observed ones. Therefore, reconsideration is required for nu-
merous aspects in this field, including the rules for cell migration, thrombus
deformation in response to the flow and retraction of platelet aggregate. Pre-
sumably, the separate case study is needed for platelet-platelet signaling, acti-790
vation and procoagulant activity before incorporating these phenomena into a
multiscale catch-all model.
Nowadays in a number of existing coarse-grained models of thrombosis the
platelets are idealized as solid spheres or material particles with the same effec-
tive radius and/or hydrodynamic properties as those in the real life. Such an795
approach reduces the computational costs compared to full-cell shape-resolving
simulation, while keeping the collective phenomena, crowding, jamming and
granular media effects taken into account [139]. This granular nature of the
thrombus or platelet aggregate usually escapes from the scope of continuum
models. But, apparently, the mechanisms involved into thrombosis regulation800
and mechanical properties of thrombi depend strongly on the density and the
inner structure of platelet aggregates.
One of the hypothetical mechanisms of the thrombus growth regulation is
based on the interaction of the platelet- and plasma-dependent hemostasis. It
was suggested that a fibrin-reinforced “core” is formed within the thrombus.805
This idea is supported by recent experimental data [114]. This “core” is practi-
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cally non-destructible by the flow, however, the outer regions the platelet throm-
bus (above the fibrin core) are loosely packed and could be disrupted and re-
moved by flow. This externalizes the inert fibrin that prevents further platelet
attachment and stops further growth of a thrombus. This hypothesis is sup-810
ported by a simulation study [10, 12] that employs a hybrid DPD-PDE model
in order to grasp the interplay between platelet adhesion and plasma coagula-
tion in microvascular flow conditions. Dissipative particle dynamics (DPD) was
used to model plasma flow with platelets while fibrin concentration is described
by a simplified reaction-diffusion-advection equation. Platelet activation and815
emergence of strong connections were modelled as a time-delayed strengthening
of bonds, and platelets covered by fibrin with a sufficiently high concentration
could not attach new platelets. The use of time dependent platelet adhesion
force allowed the creation of a clot core, in which the forces between platelets
are stronger than the ones between the newly connected platelets in the outer820
part of the clot. Similar approach to platelet adhesion was used by Mori et al.
[129] with a distinction that the binding force between particles was modeled us-
ing the Voigt model (a spring with viscous damping). Different properties were
introduced to consider the distinct behaviors of vWF-mediated and fibrinogen-
integrin-mediated adhesion. Significant development of thrombus formation in825
height requires not only GPIb-vWf bonds, but also the activation of integrins.
In general, despite its simplicity, this kind of models can give an insight into the
mechanisms of clot growth and clot rupture.
Another example of hybrid particle-PDE multiscale models was proposed
by Flamm et al. [128]. It consists of 4 submodels: a lattice kinetic Monte830
Carlo tracking platelet motion and adhesion, a neural network model of platelet
calcium signaling, a finite element method for calculation of concentration fields
of ADP and TxA2 in plasma, and lattice Boltzmann submodel to determine
the velocity field of the blood flow. Notable feature here is a neural network
model trained on each donor’s pairwise agonist scanning experiment and then835
embedded into a multiscale Monte Carlo simulation of donor-specific platelet
deposition under flow. Such multiscale model could be feasible for patient-
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specific predictions of platelet deposition and drug response. It was the first
such approach to make donor-specific predictions of platelet function under flow
in the presence of both released ADP and thromboxane.840
The initial adhesion of platelets on the thrombogenic area is governed by
a variety of receptor-ligand interactions, such as a membrane receptor complex
glycoprotein Ib-IX-V (or shortly GPIb) on platelets with von Willebrand Factor
(vWF) multimeric protein. At low shear rates (below 1000/s), platelets adhere
to the thrombogenic area through different pathways, relying on the exposed845
extracellular matrix proteins, while as shear rate increases, interactions between
immobilized vWF and GPIb become exclusive in initializing platelet aggregation
[112]. The vWF proteins, which normally reside in a coiled state, tend to uncoil
and expand in high-shear environments [140]. This conformational change leads
to enhanced adhesiveness of platelets. In recent work by Yazdani et al. [117]850
a shear-dependent platelet adhesive model has been proposed. The authors in-
troduced an Eulerian-Lagrangian model where hemodynamics was solved on a
fixed Eulerian grid (via Navier-Stokes equations), while platelets were tracked
using a Lagrangian framework (via velocity-interpolation approach). The reac-
tive transport of chemical species on a fixed Eulerian grid was also considered.855
The model of adhesion was based on the Morse potential with a shear-dependent
potential well depth. The model is able to predict thrombus occlusion time with
no significant computational cost using a data extracted from different experi-
ments.
The role of platelet concentration is very important in coarse-grained simula-860
tions, especially when red blood cells are discarded from the model. The efficacy
of platelet adhesion in shear flow is known to be substantially modulated by red
blood cells [141, 20, 21]. The near-wall excess (NWE) of platelets augments
the frequency of platelet-wall collision, which aids in the hemostatic function
of platelets [142, 143, 9]. A reasonable way to account for the platelet excess865
without RBCs is to set a higher homogeneous concentration of platelets in the
inlet [116], or to prescribe the distribution of platelets according to experimen-
tal data [117]. Besides that, a special boundary inflow and outflow conditions
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are required for platelet species in the model in order to maintain the constant
concentration or rate of platelets that enter the simulation box, and dispose870
those cell and aggregates that leave the box with the fluid. Taking into account
that fluid velocity field also may be disturbed by the platelets, a simple peri-
odic condition may fail. Probably, special in-/out-flow buffer areas, like those
proposed in [121], would be an efficient and accurate solution. Another issue is
how to rescale the adhesive forces when substituting the platelet with a sphere875
or material point. These questions in principle may be resolved with help of
more detailed high-resolution cell-based models, which we discuss below.
The adhesion of platelets is to a great extent governed by its motion regimes
in a shear flow and hydrodynamic interaction with erythrocytes and the wall.
The flipping motion of a blood platelet convected under the action of a near-wall880
shear flow was modelled in pioneering works by Pozrikidis [132, 133] by means
of a spectral boundary-element method. Later, Mody and King [130, 131] pre-
sented a detailed study of the collision and aggregation a pair of free platelets
near a plane wall via boundary integral equation method for 2D hydrodynamic
modelling coupled with platelet adhesive dynamics simulation. Platelet aggre-885
gation behavior was studied as a function of the binding kinetics of healthy
(and reversible) GPIba-vWF- A1 bond formation. Also the influence of wall on
platelet aggregation was investigated. Platelet collision behaviour is found to be
strikingly different from that of spheres, both close to and far from a bounding
wall. It was concluded that the mechanics of inter-platelet collisions is a func-890
tion of particle shape and proximity of physical flow boundaries. The platelet’s
unique spheroidal shape provides heterogeneous, orientation-dependent rolling
behavior which enhances cell-wall and cell-cell interactions, which are critical
for initial stages of thrombus formation [144].
Two-dimensional model of platelet motion near a thrombus surface by Fo-895
gelson et al.[145] also demonstrated the importance of platelet oblate spheroidal
shape for its ability to adhere. But this work revealed the influence of thrombus
porosity on cell dynamics near the thrombus. For thrombi with pores suffi-
ciently large to contain a platelet, platelets did not pass over the thrombus, but
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instead penetrated into the thrombus where they became trapped. The median900
time that platelets spent in close proximity to the thrombus also was higher
for more porous thrombi. These platelets would have a significantly increased
time to respond to activation signals and firmly adhere to the thrombus via
integrin-mediated bonds. The authors concluded that this may help to promote
early growth of the thrombus. The importance of platelet-RBC collisions was905
stressed in this paper, indicating the fact that further simulation studies should
account for this phenomenon.
Due to the computational costs of direct shape-resolving and bond-resolving
simulations of platelet motion and adhesion, the bibliography is plenty of 2D
models. Such models are able to simulate only small number of cells on a910
timescale of several seconds, but not the whole occlusive thrombus dynamics.
Modern approaches use 3D hydrodynamic approaches and incorporate RBCs
into consideration [146]. Limited applicability of platelet-only models discour-
ages their development and application. However, these are promising for re-
vealing the complexity of platelet-platelet adhesion mechanisms, their activation915
and signaling. And there is a lot of space for fundamental research in this sub-
field to the date.
5.1.4. Modelling of ligand-receptor cell adhesion
The adhesion and fragmentation of cells is ubiquitous in biological systems.
The adhesive forces are composed of numerous physical processes including920
ligand- receptor binding kinetics, surface deformations, fluid flows, etc. Most
of contemporary approaches rely on the idea that bond formation and break-
age could be viewed as a statistical process modelled as a reversible chemical
reaction between the populations of free membrane receptors (or cell adhesion
molecules, CAMs) and their ligands. These reactions could be characterized by925
forward kon and reverse koff reaction rates. Most of the CAMs belong to four
protein families: immunoglobulin superfamily, the integrins, the cadherins, and
the selectins. There is distinction in their structure and mechanisms: usually
the classifications distinguish between calcium-independent CAMs and calcium-
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dependent CAMs, some CAMs demonstrate high selectivity and require a spe-930
cific ligand to attach (GPIb platelet receptor, ), others are less selective and may
interact with many ligands (like GPIIb/IIIa of the platelets which can bind to
vWf and fibrinogen). Nevertheless, the basic principles of their action could be
described in a common way.
Bell was first to adapt the kinetic theory of the strength of solids and pro-
posed a constitutive relation between dissociation rate and force [147]:
koff = k
0
off exp(−F/FD), (28)
assuming kon constant. Here FD is the typical force required to apply for bond
dissociation. This relation implies that the stronger the stretching of the bond,
the shorter its mean lifetime. Another variation is to use a power law instead
of the exponential law as proposed in [148, 149]. Also constitutive equations of
the similar exponential force-dependent form have also been proposed for the
binding affinity [150, 151]. Later Dembo and co-workers [152, 153] proposed a
modification to original Bell’s formula, including the ratio of elastic energy to
kT into exponent, instead of forces. The authors went further introducing the
mathematical description for the so-called catch- and slip- bonds. It was done
by assuming that a spring of the receptor has different stiffness in the bonded
(K) and non-bonded (transition) state (Kts) :
kon = k
0
on exp
[
−βKts(l − l0)
2
2
]
, (29)
koff = k
0
off exp
[
β(K −Kts)(l − l0)2
2
]
, (30)
where β is the inverse of thermal energy, l0 is the equilibrium (non-stretched)935
bond length. If Kts > K, then the mean life-time (1/koff) of the highly stretched
bond will be longer than that for the unstressed bond (1/k0off). This counter-
intuitive behaviour has been debated for many years until the existence of catch-
bonds was experimentally detected in bacteria [154] and a year later in leuko-
cytes [155]. It is believed that the physical principle of catch-bonds is related940
to conformational transitions in CAMs, similar to a Chinese finger trap. The
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exact mechanism is still being debated [156, 157, 158]. There are evidences that
catch-bonds are also involved into initial platelet adhesion via GPIb-vWf bonds
[159, 160].
Based on this findings, the numerical and semi-analytical model for leukocyte
was proposed by Hammer and co-workers [161, 162, 163]. Within this approach
the adhesive force and torque are calculated by integrating over the active bonds
in the gap between adhering surfaces. The number of bonds per unit area nb
at each particular moment of time could be found by solving the corresponding
PDE:
∂nb
∂t
+ u · ∇nb = kon(Nl − nb)(Nr − nb)− koffnb (31)
with the boundary conditions that bonds should vanish outside the adhesive
contact zone. Here Nl and Nr are total numbers of ligands and receptors in
the contact respectively. Within this continuum approach nb(x, t) may be in-
terpreted as the probability density of finding the active (attached) bond in a
particular place at particular moment of time, since the process of bond forma-
tion and rupture is stochastic. In limiting case of weak affinity and abundant
binding receptors on the surface of adhesion the bond density evolves as the
following differential equation
∂nb
∂t
+ u · ∇nb = konNlNr − koffnb. (32)
Let us consider as an example the problem of pulling apart (at constant
velocity U) two parallel plates with ligand-receptor bonds forming in the gap.
Introducing the dimensionless variables, the equation 32 reads:
∂N
∂T
= K0on · exp
[−Kts(H − 1)2]−K0off · exp [(K −Kts)(H − 1)2]N. (33)
Here N = nb/Nr, K = κl
2
0β/(2), Kts = κtsl
2
0β/(2), K
0
on = k
0
onNll0/U , K
0
off =
k0off l0/U , H = h/l0 and dimensionless time T = tU/l0. The term u·∇nb vanishes
due to geometry of the problem: the velocity is normal to plates and nb depends
only on the lateral coordinates. We will solve this equation with respect to
initial conditions N(0) = 0, H(0) = 0. The distance between plates evolves as
h(t) = Ut, or H(T ) = T . In case of slow quasi-steady motion U  l0k0off the
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bond density may be approximated by the equilibrium value Neq obtained from
the steady solution (∂N/∂T=0) of Eq.33:
Neq = Keq · exp[−K(H − 1)2], (34)
where Keq = K
0
on/K
0
off is the equilibrium constant for the binding reactions.
This solution suggests that the number of bonds in the gap is mainly governed
by the ratio of reaction rates and the distance between plates. Stiffer bonds
(greater K) break at smaller distances. The transition state stiffness Kts does
not influence the equilibrium density of bonds, as the average time for a bond
being in a free (transition) state is much smaller than typical time of the problem
l0/U . In general case, however, the solution will depend on Kts leading to
notable consequences for adhesion force. The general solution to 33 reads
N(T ) = exp(−I(T )) ·
(∫ T
0
Kon(T1)e
I(T1)dT1
)
, (35)
with
Kon(ξ) = K
0
on · exp
[−Kts(ξ − 1)2] , (36)
Koff(ξ) = K
0
off · exp
[
(K −Kts)(ξ − 1)2
]
, (37)
I(T ) =
∫ T
0
Koff(ξ)dξ. (38)
Results of direct numerical integration of Eq.33 are presented in Fig.9: dif-
ferent lines correspond to different transition state stiffness Kts. The slip bonds
Kts < K eventually rupture as the plates are being separated leading to decrease
of adhesion force density. In contrast, catch bonds Kts > K remain longer in
the stressed state than in the free state. Their lifetime increases as plates are
being separated, this is why we see linear growth of adhesion force per unit area:
σz = −nb(t) · κ[h(t)− l0], (39)
or in dimensionless form
Fz = σzl0/(2NrkT ) = −N(T ) ·K[H(T )− 1]. (40)
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Figure 9: Numerical solution of the Eq.33. (a) Density of bonds N versus dimensionless time
T = tU/l0. (b) Resulting dimensionless normal adhesion force per unit area (−σz)l0β/(2Nr)
as a function of dimensionless time T . The parameters are as follows: K0on = 0.1, K
0
off = 1.0,
K = 0.1. Different lines correspond to different transient state stiffness parameter Kts = 0.05
(solid), 0.09 (dashed), 0.13 (dash-dotted), 0.15 (small dots), 0.2 (bigger dots).
This simple phenomenological model grasps the unusually long-lasting bonds945
in leukocytes [161] and platelets [160]. However, this model is not the only
possible one, and the mechanisms of catch-slip behavior may depend on the
individual allosterical properties of a ligand-receptor pair. For instance, two-
pathway allosteric model [157, 164] relies on the assumption of the existence of
two possible conformations, each of which decreases its lifetime with the force950
applied (as a normal slip bond does). But the transition between these states
is biased so that the life-time of a lower-energy state becomes bigger with force.
This model successfully explains the adhesion of Escherichia coli bacteria [157]
via the FimH adhesin.
For the case of a shear (sliding) motion of plates, cylindrical and spherical
particles a similar formalism could be allied. The results can be found in [165,
163, 166]. In case of shear motion the bond tilting should be taken into account
[165]. By introducing a finite resistance to bond tilting (harmonic potential
with stiffness Kθ), the reaction rates in non-dimensional form read
Kon = K
0
on · exp
[−Kts(L(H, θ)− 1)2 −Kθθ2] , (41)
Koff = K
0
off · exp
[
(K −Kts)(L(H, θ)− 1)2
]
(42)
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with L(H, θ) = H(1 + tan2 θ)1/2, H = const and the bond density evolution
equation with its boundary condition:
√
 ·G∂N
∂T
= −U ∂N
∂X
+Kon −KoffN, (43)
X →∞, N → 0, (44)
assuming that U < 0 and there is no advection of bonds from downstream,955
 = l0/R, where R is the radius of a cell and G is the dimensionless shear rate.
Two distinct types of macroscale cell motion were predicted: cell rolling or cell
sliding with bonds providing weak frictional resistance to sliding. The model
predicts bistability between these two states.
Remarkably, such an approach is also applicable in Lagrangian simulation
frameworks, like the immersed boundary method, the finite element method and
the boundary integral method. Thus it could be coupled to hydrodynamics of
cells of any complex geometry. Mody and King [131] analyzed the aggregation of
blood platelets using the model inheriting from the pioneering works [152, 161].
Instead of solving the master equation for bond density, they accounted explic-
itly for every individual bond between Lagrangian surface points on platelet
membranes. Only the adhesion via GPIb-vWf was considered. Since this type
of bond relies on a solvable ligand vWf, a specific procedure was involved into
the algorithm. Monte Carlo simulations were performed to test for the forma-
tion of new bonds between receptors on surface of one platelet, bound and free
vWF ligand molecules, and receptors on another platelet. Bond formation and
dissociation was tested using probability probability of bond formation Pon and
the probability of bond breakage Poff :
Pon = 1− exp(−kon∆t), (45)
Poff = 1− exp(−koff∆t). (46)
In [131] it was assumed that all A1 domains of vWF molecules were in ac-960
tive “bindable” state. However, the authors did not consider subpopulations of
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adhesive molecules that can switch to non-bindable state (GPIIb/IIIa), neither
accounted for the catch-slip transitions in GPIb [160]. Insufficient quantifica-
tions of such phenomena in the literature preclude the development of models at
this time. To date, mostly the Bell-like models have been used to describe the965
GPIb-vWf dissociation kinetics. Unfortunately, most of them do not account for
the shear threshold effect exhibited by platelet interactions with surface-bound
vWF [140], autoinhibition of vWf-A1 by the neighbouring vWf-A2 domain [167]
and other microscopic phenomena that might be relevant for platelet aggrega-
tion during thrombosis. There is a critical need for the development of more970
detailed GPIb-vWf binding kinetic models with a greater physiological rele-
vance. In addition, the models of activation and binding kinetics for platelet
adhesion receptor GPIIb/IIIa are still to be implemented and validated.
5.2. Coagulation in presence of platelets
Vascular injury exposes the subendothelium and clot-promoting proteins:975
collagen, tissue factor and von Willebrand factor. They also activate the bound
platelets causing them to release soluble chemical agonists into the plasma where
these can activate other platelets and promote plasma clotting. Despite exten-
sive research and great practical importance, there are only few models that
attempt to simulate the interplay between plasma coagulation and platelet ag-980
gregation during thrombosis and hemostasis.
The influence of platelets on coagulation is not just chemical. The dense
platelet aggregate in the site of injury provides a scaffold for the thrombin and
the fibrin gel. The porosity of platelet aggregates slows down the flow velocities
and diminished the wash-out of plasma coagulation factors - thus in arterial con-985
ditions with high flow velocities the effective coagulation is impossible without
platelets. The studies by Fogelson et al. indicate that at least for small injuries
the flow-mediated dilution is the most potent inhibitor of the plasma clotting
cascade [101, 116]. It was found that the importance of the thrombin-fXIa-fIXa
feedback loop to robust thrombin production depends on the concentration of990
platelets in the blood near the injury [116]. In their model the authors assumed
49
that each chemical or platelet species were well mixed in the reaction zone. The
concentration of each protein satisfies an ordinary differential equation (ODE)
that includes terms for reactions; the same approach was used for platelets. It
was assumed that the reactions could occur in a reaction zone above a small995
patch of exposed subendothelium, and the height of the reaction zone was able
to increase together with the total volume of platelets in the thrombus. Ad-
vection of species has been accounted only away from the reaction zone, which
may be reasonable for the conditions inside stable platelet aggregates, where
flow is hindered, or under venous conditions. These approximations reasonable1000
for small thrombi are not applicable to larger thrombi that grow substantially
into the vessel lumen. For larger injuries, in order to account accurately for the
interaction between growing thrombus and the flow, a more complex spatial-
temporal model is required. Interestingly, in the model by Fogelson et al. the
membranes of activated platelets provided coagulation reactions for factors and1005
their complexes (e.g. dimerisation of fXI or fXIa).
Figure 10: Numerical simulations of clot growth with the DPD-PDE method. Blood flow
and platelets (green dots) are modeled with a particle (DPD) methods, the distribution of
blood factors with reaction-diffusion-advection equations. Clot growth begins with platelet
aggregation. They protect the injury site from the flow allowing the coagulation cascade to
start (a). Fibrin network (blue) forms inside the platelet aggregate and reinforces the clot
(b). The outer part of the platelet aggregate is removed by the flow giving its final size and
shape (c). Reprinted with permission from [12].
In a hybrid DPD-PDE model by Tossenberger et al. [10, 12] the fibrin gel
formation was modelled along with particle dynamic simulation of plasma flow
and platelet adhesion. Because of the complexity of the coagulation process,
the authors implemented a simplified model of the coagulation cascade where1010
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the distribution of blood factors are described by reaction-diffusion-advection
equations. Several techniques, such as an introduction of the exchange period
between DPD and PDE solvers, bilinear interpolation for concentration fields,
etc., were introduced to couple the mechanical and chemical blocks of the model.
The model shows the following clot growth process. At first, an early platelet1015
aggregate forms at the injury site, which is necessary to protect the concentra-
tions of blood factors (especially thrombin) not to be taken by the flow (Figure
10, a). Let us note that the first platelet aggregate can form before platelet
activation. Their activation leading to the reinforcement of their connections
occurs already in the clot. In that way blood coagulation can occur inside of1020
the platelet clot. As a final product of blood coagulation, fibrin polymer is pro-
duced, reinforcing the inner part of the clot, thus forming the clot core (Figure
10, b). The clot core, which is more stable, can support further clot growth.
As the clot grows, the blood vessel becomes narrower and the flow shear rate
increases at the top of the clot. Due to the increased shear stress the softer1025
outer parts of the clot, which are not covered by fibrin polymer, are one by
one detached and taken by the flow. This process continues until clot stops
growing (Figure 10, c). The hybrid model in this work is simple from biological
point of view, but as such offers some useful insights in flow-thrombus-protein
interaction and serves as a good base for future model development.1030
The most blurry issues in the field of platelet-plasma interactions during
thrombosis are related to platelet activation and signal transduction. Activa-
tion of each platelet that occurs at the earliest stages of the thrombus formation
is an extremely complicated process that includes shape change, granule secre-
tion, etc., and is regulated by an immense signaling network that is only partially1035
deciphered. This module does not require hydrodynamics but is extremely chal-
lenging from the biochemical point of view: most reactions are poorly known,
and their parameters have not been determined. As for the network of blood co-
agulation, this part is well-studied, except the poorly known mechanisms of the
membrane-dependent reactions [8] and in-flow fibrin polymerization dynamics1040
[98].
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6. Role of blood cells: Erythrocytes
6.1. Continuum models
High concentration of red blood cells (RBCs) gives rise to the complex non-
Newtonian rheology of blood, as well as to collective effects from cell-cell colli-1045
sions.
On the one hand, PDE-based classical hydrodynamic-concentration models
could be used by modifying the Navier-Stokes equation with phenomenological
non-Newtonian viscous stress-tensor [168, 169], or a constitutive equation [170].
The model will remain relatively simple, efficient and scalable. The rheology,1050
however, is not the main complexity that RBCs bring to the problem of throm-
bosis, and in most thrombosis-related cases non-Newtonian properties of blood
may be neglected [169]. Which is more important, it has been experimentally
discovered [141] that platelets accumulate on the adhesive substrate faster in
presence of erythrocytes, than in platelet reach plasma or buffer, due to platelet1055
redistribution in blood vessel caused by their mechanical interaction with RBCs
[9]. In [11] the implicit effect of RBCs has been accounted by the analytically
approximated phenomenological dependence [20, 21] of platelet accumulation
rate on wall shear rate. This non-linear effect of RBCs on platelet adhesion
appeared to be important for hydrodynamic regulation of thrombus growth in1060
microvasculature.
Only few works use continuum-based approach with implicit accounting of
RBC effect on thrombosis [119, 171, 20]. Such models present spatial and tem-
poral evolution of a thrombus via concentration functions (for both cells and bio-
chemical agents), while effects of RBCs are accounted via effective diffusivities1065
[171, 20] or by adjusting inlet platelet concentration profile so that platelets ac-
cumulate near vessel wall [119]. Due to computational efficacy, these approaches
are able to track the dynamics of thrombosis in larger vessels on a timescale of
several minutes, even hours. Yet the important constants and parameters (e.g.
diffusivity of platelets, thrombus elastic moduli and porosity, platelet accumu-1070
lation rates, etc.) could mostly be obtained by fitting experimental data. Thus,
52
we see that the internal physics and biomechanics of thrombosis and hemostasis
may escape from the scope due to phenomenological assumptions. Cell distri-
bution across blood vessels, platelet activation and signalling, crack formation
in platelet aggregates, and RBC collisions with thrombus might be important in1075
understanding mechanisms of thrombosis regulation. The physical backgrounds
of some effects remain unclear, until detailed cell-cell interactions are consid-
ered explicitly. Although continuum models fail to provide mechanistic picture
of RBC impact on thrombosis, nevertheless they could be tuned to reproduce
the correct phenomenology. The main advantage is their scalability (both in1080
time and space) and easy implementation on the basis of CFD numerical meth-
ods. Due to its relative simplicity, this class of methods is the first candidate to
engineering and medical applications.
On the other hand, modelling blood as a suspension of RBCs allows one
to inherently capture important rheological and transport properties of blood1085
ab initio. Such direct simulation approach is considered to be appropriate in
a number of studies, where the number of interacting objects (e.g. colliding
blood cells) is large, but continuum approach is not sufficient. Blood rheology
is probably the most notable and famous example [172, 173], since it depends
on cell-cell and cell-fluid interaction and could only be reproduced correctly if1090
blood cells and their mutual collisions are modelled explicitly. Another example
important for thrombosis and hemostasis is the phenomenon of blood platelet
margination to the regions nearby the vessel wall [9, 174, 175, 176]. This effect
is interconnected with important biomechanical phenomena like the Fahraeus
and Fahraeus-Lindqvist effects (caused by formation of RBC-depleted layer near1095
wall). The effect of hematocrit on platelet initial adhesion has been numerically
characterized [146] using 3D cell-resolving simulation.
Each of these effects may have an impact on thrombus growth: Non-Newtonian
rheology is important in low-shear conditions [177, 169] of venous thrombosis,
while the formation of RBC-depleted layer, platelet margination and platelet-1100
RBC collisions [20, 21] are crucial for arterial and microvascular thrombosis.
Complexity of the model and of its numerical realization should be appropriate
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to the questions under investigation. Depending on the resolution of a simu-
lation, on how detailed RBCs, their shape and mechanics are presented in the
model, one could distinguish between coarse-grained and full-cell approaches.1105
6.2. Coarse-grained models
To this class of intermediate approaches we attribute any particle-based sim-
ulation, which does not describe the exact mechanics and shapes of erythrocytes
and platelets. Models of this kind occupy an intermediate niche between con-
tinuum (macroscale) and cell-based (microscale) levels.1110
Numerous methods have been proposed to model whole-blood flows with
conventional coarse-grained methods, such as Dissipative Particle Dynamics
(DPD) [178] and Smoothed-Particle Hydrodynamics (SPH) [179] and others.
Whence nowadays it is obvious that pure particle dynamics (that means that
plasma is also presented as a particle ensemble) for whole-blood simulations is1115
tremendously costly from computational point of view, modern coarse-grained
approaches are hybrid: they combine continuum description for plasma with
particulate description for cells [180, 181, 182].
It has been seen that various mechanical factors are involved in the regulation
of primary thrombus formation through a series of physiological and biochemical1120
processes, including blood flow and intercellular molecular bonds. Nowadays, it
has become clear that RBCs influence thrombus formation mechanically (apart
from rheology) in at least two ways: 1) enhancing platelet adhesion by pushing
them to the wall of the vessel, 2) colliding into growing thrombus.
The latter one has been addressed via coarse-grained modelling [182], where1125
RBCs had been represented as elastic spheres either soft of rigid. The results
show that when red blood cells constrain the vertical growth of platelet thrombus
and the platelet aggregate spread more horizontally compared to zero hematocrit
case. This work pointed out the necessity of considering the presence of red
blood cells when investigating the mechanism of thrombus formation, and also1130
supported the idea that growth of a thrombus in vertical direction may be
hindered by its mechanical interaction with streaming blood [11].
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The impact of RBC-platelet collisions on platelet margination to vessel walls
has also been addressed via coarse-grained approaches. In [181] authors take
erythrocytes into account implicitly, guided by experimental observations, as an1135
effective “diffusion”. They added a random step (increment) to each platelet’s
motion during each iteration. The alternative implicit way to incorporate the
effect of the red blood cells also has been proposed in [181]: to exert a random
force on each platelet, pushing it to the wall. However, choosing random force
vectors and distributing the forces over the platelet’s surface appeared to be not1140
a very obvious procedure.
Another example [180] uses spherical impenetrable RBC-like and platelet-
like colloids to reproduce whole blood. Using hydrodynamic simulations of such
a simple model, authors showed that the adhesion probability of platelets to von
Willebrand factor is strongly and nonlinearly dependent on hematocrit and flow1145
rate, and that the origin of such behaviour is in the distribution of platelets.
In other words, it appeared that the understanding of blood cell redistribution
mechanisms does not require the exact mechanics of RBCs and platelets. This
achievement is quite encouraging for coarse-grained modelling.
Overall, the coarse-grained modelling of thrombosis and hemostasis is lim-1150
ited nowadays. This class of methods, being a profitable trade-off between
full-continuum and full-cell models, is able to cover partly the disadvantageous
phenomenology of continuum models, yet raises computational costs. Since
these models could not reproduce correct blood rheology (due to simplifications
of RBCs shape and elasticity) they do not find applications in engineering and1155
are being underestimated. However, these approaches have proven already the
capability to reveal and demonstrate basic mechanisms of RBC influence on
thrombosis. Therefore, coarse-grained models might be considered as a comple-
mentary illustrative tool in addition to the real-life experiments.
6.3. Full-cell models1160
The hypothesis of the formation of RBC-depleted layer near wall was recently
supported by the computer simulations [9], see Fig.11. The mechanism of this
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effect is believed to be caused by the interplay between the deformability of
RBCs and the hydrodynamic Segre-Silberberg effect [183, 184]. As shown in
Fig.12, the repulsion of RBCs from vessel walls is likely to increase platelet1165
concentration in the near-wall region, where their physiological function should
be fulfilled. This mechanism could only be numerically studied by “full-cell”
models that resolve the actual shapes and reproduce the realistic elasticity of
the RBCs and platelets. Being advantageous for the investigation of cell-cell
and cell-wall collision dynamics, these ab initio simulations are very resource-1170
demanding. Let us now discuss the advances, challenges and some technical
details of such full-cell hemodynamic models.
Figure 11: Snapshots of numerical simulations showing erythrocytes and platelets in the flow
in cylindrical channel for three different values of Ht: a) 40%, b) 20%, c) 10%. Blood plasma
particles, which occupy the remaining volume of the channel, are not shown. Reprinted with
permission from [9].
Nowadays the primary tools for micro-scale cell shape-resolving hemody-
namic simulations are as follows: the Immersed boundary method (IB), Boundary-
Integral method (BIM) and variations of mesoscopic Particle Dynamics. Mostly1175
these models comprise of three principal blocks: viscous fluid (blood plasma),
cell or cell membranes and coupling scheme that establishes mechanical connec-
tion between cells and fluid and assures the momentum conservation.
A number of works use different combinations of these techniques to de-
scribe motion of objects immersed in viscous incompressible fluid. For instance,1180
blood rheology has been addressed [177], indicating that coin-like RBC aggre-
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Figure 12: Erythrocyte (solid line) and platelet (dashed line) distributions as a function of
distance from the axis for three values of Ht: a) 40%, b) 20%, c) 10%. Reprinted with
permission from [9].
gation is responsible for increased apparent blood viscosity at small shear rates.
Platelet margination to vessel walls has also been studied. Thus, [185] ad-
dressed the importance of platelet shape via front-tracking/immersed boundary
method. With Boundary Integral simulations [146] supported the hypothesis1185
that RBC-platelet collision being involved into platelet adhesion and thrombus
formation. In [186, 145] on using 2-dimensional Lattice-Boltzmann-Immersed-
Boundary method it was demonstrated that RBCs are responsible for the devel-
opment of platelet near-wall excess and the mechanism for platelet margination
is based on excluded volume effects. Using similar approach, [176] discovered1190
that platelet clustering in aneurysms depends on aneurysm’s geometry. Most ef-
ficient are models with hybrid approaches where fluid is treated as a continuum
and cell membranes are presented as a mesh of particles.
6.3.1. Spectrin mesh model of RBCs
Every model that deals with erythrocytes at this level of details includes
the well-validated membrane constitutive model. Most of contemporary hemo-
dynamic simulations follow the pioneering works by Skalak et al. [187, 188,
189, 190], in which the mechanics of RBC’s membrane was characterized and a
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model of spectrin network for RBC’s skeleton was suggested [189, 190]. Later
a coarse-graining procedure was developed [191] allowing for an RBC to be
described with arbitrary number of vertices. The 3D spectrin-mesh model for
RBC was proposed [192, 193, 194, 195, 191], which by this moment has become
a well-validated standard in hemodynamics. The model accounts for stretching
elasticity, bending rigidity, conservation of volume and surface. It is usually
formulated in terms of Helmholtz free energy of the membrane:
W (xn) = WWLC +Wbending +Wvolume +Warea, (47)
WWLC =
∑
edges
kWLC
3ξ2i − 2ξ3i
1− ξi +
∑
edges
krep
Li
, (48)
Wbending =
∑
adjacentfaces
kb · [1− cos(θab − θ0)], (49)
Wvolume = kv
(Ω− Ω0)2
Ω0
, (50)
Warea = kag
(S − S0)2
S0
+
∑
faces
kal
(Ak −Ak0)2
Ak0
. (51)
Here ξi = Li/Lmax is the relative deformation of an i-th edge, Ak is the area1195
of a k-th face, θab is the angle between two adjacent faces a and b. The force
acting on i-th vertex is derived as Fi = −∂W (xn)/∂xn .
A set of optical-tweezers experiments on RBCs by Suresh et al. [193, 194,
196, 197] is often used to choose the parameters of membranes (bending and
stretching elastic moduli). The usual validation runs to assure that the RBC1200
mechanics is correctly formulated in a model include [198]: 1) the simulation
of optical-tweezers stretching with comparison to experiments; 2) the shear test
implying that RBC must change its tumbling motion for tank-threading at
around 1000 /s. The biconcave shape of RBCs has also been digitized and used
for initial meshing of cells in a model [198].1205
Worthy to notice that the viscosity of RBC interior is usually assumed to
be equal to the one of the blood plasma. This is not strictly correct, but the
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Figure 13: A scheme of the Lattice Boltzmann- Immersed Boundary simulation method for
blood flows.
assumption reduces the model’s complexity drastically: single-phase viscous
fluid dynamics is easier to compute compared to two-phase fluid dynamics.
Only a limited number of works account for a viscosity contrast in RBCs in their1210
models [199]. In particular, it was shown that the transition from tank-treading
to tumbling motion can be triggered by the ratio between internal and external
fluid viscosities [199], influencing the rheology of the modelled suspension.
6.3.2. Technical details: LBM-IB approach
One of the possible schemes is based on the combination of immersed bound-1215
ary and lattice Boltzmann methods (IB-LBM) [186, 200, 145, 201, 135, 202, 198,
203]. Within such a framework RBCs are represented as a mesh of Langrangian
surface points, interacting via a constitutive elastic membrane model (Fig. 13).
LBM is employed to calculate velocities in the fluid phase. Its main advantages
are that it converges if Reynolds and Mach numbers are smaller that unity,1220
regardless of a node-mesh structure (thus, no need to refine fluid nodes mesh
in complex geometry, etc.) and a relatively simple parallelism. LBM is coupled
to the suspended RBCs with the immersed boundary method via the procedure
of interpolation of velocities and forces between movable membrane nodes and
stationary lattice nodes.1225
Basically, LBM is used as a fast solver for hydrodynamic equations, that
inherits from lattice gas automata simulations. The method rests upon the
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kinetic equation that describes the spacial-temporal changes of a one-particle
distribution function [135]. In other words, the main quantity f(x, c, t) corre-
sponds to the probability distribution of finding fluid particles (molecules) in
site x, at time t, moving with velocity c. Being discretised in a 6-dimensional
phase space via a regular mesh of spacial sites {x} and lattice velocities {ci},
this function fi(x, t) obeys the following equation:
fi(x + ci∆t, t+ ∆t) = fi(x, t) + Ωi(x, t), (52)
and the evolution of the system could be found by consequent iterations. Here
fi(x, t) ≡ fi(x, ci, t). Different schemes and lattices were proposed. The most
widespread for 3D simulations is D3Q19 scheme, which means that 3-dimensional
square lattice of spacial (Eulerian) sites are used with 19 unity velocity vectors
ci. The most intriguing part is the collision function, that determines the inter-
action of fluid particles with each other, thus governing the macroscopic prop-
erties of the media. For viscous incompressible fluid the single-relaxation time
approximation (or Bhatnagar-Gross-Krook approximation) is usually preferred:
Ωi(x, t) = −1
τ
(fi(x, t)− f eqi (x, t)) + Ω˜i(x, t). (53)
Here the relaxation time τ unequivocally defines the kinetic viscosity of the fluid
ν = (τ − 0.5)c2s∆t,where cs = (1/
√
3)(∆x/∆t) is the so-called “lattice speed of
sound”. The equilibrium distribution function f eqi (x, t) corresponds to the series
expansion of Maxwell-Boltzmann distribution for small Mach numbers. The
additional term here Ω˜i(x, t) is caused by the coupling forces F(x, t) between1230
the blood cells and the fluid (and/or any external force field) [203].
The immersed boundary method (IB) is a coupling method applicable for
the description of dynamics of cell membranes immersed in blood plasma [202].
This is however, not the only application, as a number of works use IB for
the granular media and suspension flows simulations. A great advantage of
IBM, is that the fluid and the immersed structure (cell) do not need to conform
via their meshed or grids, thus there is no need for remeshing. The central
idea of IB method is the coupling between a viscous incompressible fluid and a
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number of moving deformable objects in contact with that fluid. Fluid drag and
normal stresses agitate motion of the objects and objects (blood cells) in their
turn influence the motion of the fluid. The elastic cell membrane is described
in Lagrangian terms: Langrangian surface points (or surface particles) which
constitute the membrane mesh, exert a force to the fluid, and the fluid advects
the surface particles to their new positions by interpolating the fluid velocity.
The surface particle belonging to the cell membrane Xi(t) spreads the total
force Fi(t) exerted on it to the closest fluid-grid points x:
F(x, t) =
∑
i
Fi(t)δ(x−Xi(t)) (54)
with interpolation kernel (discrete Dirac delta function) δ(x − Xi(t)). This
force field F(x, t) is exerted on the fluid via Ω˜ term in Eq.(53) (see References
[203] and [204] for details). The membrane particles gain increment to their
coordinates
xi(t+ ∆t) = xi(t) + ui(t+ ∆t)∆t, (55)
as they are advected by the nearby fluid with the velocity
ui(t+ ∆t) =
∑
x
ui(x, t)δ(x−Xi(t)). (56)
6.3.3. Efficiency, stability and convergence on example of LBM-IB scheme
The LBM is stable for small Mach numbers Ma 1, so that any velocities
in model system should be much lower than lattice speed of sound U  cs =
(1/
√
3)∆x/∆t, where ∆x is a Lattice unit and ∆t is the time-step for iterations
[135]. Convergence of the solution to the incompressible Navier-Stokes equations
for a chosen Reynolds number is obtained by letting the lattice Mach number
U/cs become small enough to remove compressibility effects. In terms of lattice
parameters the convergence for a given Reynolds number could be achieved if
the following condition is satisfied:
√
3∆tU
∆x
 1, (57)
which implies that either decreasing time step ∆t or mesh refinement ∆x provide
convergence. While in the latter case the efficacy may be maintained by the
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proportional increase of processors, in the first case the increase of the number
of iterations is needed to reach the same flow evolution time. For a given
Reynolds number Re one can reformulate this conditions in the following way:
∆x
√
3L
Re(τ − 0.5) , (58)
where L is the spacial scale of the system.
Taking into account that in microvascular (L < 100 µm) blood flows Re ≤
0.1 this means that ∆x is not very strictly bounded by the stability of the Lattice1235
Boltzmann method. Usually, the main reason to refine the mesh is the need to
resolve the lubrication interactions between individual cells, for which ∆x < 1
µm is required. If the distance between two objects (cell membranes) is less than
one lattice unit, then the “lattice fluid” can no longer “flow” between them, and
they stick together due to Lattice Boltzmann specificity. Therefore, condition1240
∆x < 0.1 µm might be required to resolve the lubrication dynamic between
cells. Fortunately, the growth of computational time following the increase
of the number of lattice sites could be compensated by the usage of massive
parallelism. However, the time step should also be decreased, first, to obey
Mach-number limitation and, second, to provide stable membrane dynamics1245
computation (so that the increment to membrane position is not too large).
Normally, the stability is achieved for ∆t ≤ 1 µs, which implies that to simulate
1 second of physical time, it is necessary to perform at least 1 million iterations.
Unlike, the spacial scaling, this time-stepping efficacy is the most limiting part
of probably every full-cell approach. And this could not be solved by parallelism1250
(neither MPI, nor GPU) directly. Multi-time-stepping approach has been proven
to be advantageous in this case. Another opportunity is the computational boost
from field-programmable gate array (FPGA) schemes, which has not been tried
for hemodynamics yet (to our knowledge).
Performance tests revealed that membrane model (computations of elastic1255
forces, bending forces, synchronization between subdomains, etc.) is the most
consuming part of these hybrid methods, followed by the Immersed Boundary
membrane dynamics [201]. The Lattice Boltzmann fluid (plasma) dynamics is
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still the fastest part of such a hybrid model, in case that the model parameters
are appropriately set up.1260
6.3.4. Alternative approaches
Several variations exist, like the substitution of LBM with conventional
Navier-Stokes [205, 178] and/or usage of different fluid-cell coupling [178, 206].
For example, Moving Particle Semi-Implicit method [207, 208] based on Navier-
Stokes equation solver combined with Lagrangian particle dynamics, which was1265
quite successful in describing motion of malaria-infected RBCs in narrow vessels.
Smoothed Dissipative Particle Dynamics (SDPD) [209] method has been
used by [210] to study WBC margination in whole blood flows. This method
combines two frequently employed approaches: smoothed particle hydrodynam-
ics and fluctuating nature of dissipative particle dynamics (DPD). The approach1270
to blood simulation was widely used: blood cells were represented by a network
membrane model, using triangulated surfaces with curvature and stretching
elasticity, the blood cells were suspended in a Newtonian fluid (plasma), which
is represented by a collection of SDPD particles. Cell membranes were coupled
to a background fluid (blood plasma) through viscous friction, in contrast to1275
the LBM-IB method describe above.
Another set of publications took advantage of Boundary Integral Method
[211, 174, 146] to solve the boundary integral equations for Stokes flow. These
equations express conservation of momentum as a relation between the velocity
of an object (cell) and the applied force. This approach is a common numerical1280
computational method of solving linear partial differential equations that have
to be formulated as integral equations (i.e. in boundary integral form). It is
only applicable to problems for which Green’s functions can be calculated. The
Green’s functions, or fundamental solutions, are often problematic to integrate,
especially for complex geometries. Nevertheless, Boundary Integral Method1285
(BIM) works by constructing a “mesh” over the modelled surface, rather than
in the whole space, therefore, it is often more efficient than finite elements
method.
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6.3.5. Parallelism and related issues
Simulations of dense blood-like suspensions require considerable computa-1290
tional resources. Parallel computations could be advantageous in this class
of problems. However, the software, in terms of algorithms, data structures
and parallelism, is complex when dealing with hybrid models with a number
of modules of distinctive efficiency. A number of new techniques had to be
developed before the large-scale cell-level simulations of blood flows could be1295
performed. For instance, complexity of a problem increases rapidly when deal-
ing with boundary conditions, moving objects, and suspended particles, and
parallelism may not be straight-forward in these cases due to synchronization
between nodes and processors. New algorithms are required, as well as the
control of data structures and streams, efficient scaling and domain decompo-1300
sition. For instance, finding neighbouring particles for cell-cell interactions can
be a time consuming task and cell-lists (analogue to Verlet-lists) can reduce
potential complexity from O(N2) to O(N), which is crucial when the number
of particles N becomes large.
Domain decomposition has its limits. This means that one cannot just exten-1305
sively overcome the complexity by increasing the number of MPI-nodes carrying
out the simulation. The parallelism usually assumes the domain-decomposition
of the fluid field, and the subdivision of cell-membrane particles follows this
partition. However, as the membrane particles interact with each other forming
a consolidated object - a cell - the communications have to be set and controlled1310
between subdomains, when a cell travels from one subdomain to another. For
these reasons, envelopes were proposed [201]. Envelopes are the boundary nodes
communicating in the domain-decomposition approach, also commonly referred
to as ghost nodes. This allows for a direct identification of the particles that be-
long to the envelopes and communicate them to the neighbouring subdomains.1315
Optimizing communication is an important aspect of the implementation.
Another issue is that different modules of a software have different efficacy.
The most demanding is the membrane-mechanics module, while the fastest is
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fluid module (especially if implemented via Lattice Boltzmann approach) [201].
Overall, cell-based models are detailed and can help to understand the im-1320
portance of cell-cell interactions and effects on the subcellular scale, yet the
computational difficulties limit their applicability nowadays to short timescales
(seconds, tens of seconds), whence thrombosis and hemostasis processes usually
take tens of minutes. The search for new soft- and hard-ware solutions is open,
however. New advances in computational sciences and computing technologies1325
(FPGA, GPU, etc.) are very promising.
7. Perspectives and future challenges
Mathematical modelling of thrombus formation has achieved remarkable so-
phistication. In the previous sections we have stated the milestones in the
construction of models in the field of haemostasis. These works investigate sub-1330
systems within thrombus formation (such as thrombin generation) as well as the
establishment of links between different subsystems, e.g. plasma clotting, sig-
nalling, platelet aggregation and activation, fluid dynamics, chemical reactions,
etc. These models allow us to take note of the influence of these links. For
example, we can notice the influence of hydrodynamic flows which are crucial1335
for all scales present in the system from the biochemical (protein) level to the
macroscopic one. The modelling is also aiding in the establishment of similar-
ities between the behaviours of plasma clotting and platelet aggregates under
flow.
The ideal, state-of-the-art model would comprise a full mathematical de-1340
scription of thrombus formation in flow that included the reactions of the co-
agulation cascade, interactions inside and between the cells in blood (platelets,
red blood cells and ethrocytes) as well as haemodynamic considerations. This
would be highly complex model and its construction is not just a theoretical
challenge but a biological one, especially where insufficient knowledge is leading1345
to model uncertainty, though of course modelling attempts can also aid with
validating biological hypothesis surrounding this uncertainty. But this is worth
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attempting, the outcome of such an approach could be very important for both
fundamental science and practical medicine.
The development of any theoretical model of a biological system such as a1350
thrombus has the dual aim of increasing our understanding of the system in
question and the ability to make accurate predictions. Theoretical models of
thrombus formation are currently fulfilling the first of these aims and increasing
attempts are being made at producing models that are accurate and/or have
their accuracy (or inaccuracies) quantified. The ability to make these accurate,1355
and indeed quantitative, predictions relies on the accuracy of the model’s pa-
rameter values. But, the vast majority of a model’s parameters are difficult or
impossible to measure experimentally, for example the immunoassays utilised
to describe intracellular changes are limited by the availability and quality of
antibodies, therefore modellers have traditionally relied on parameter values1360
that have been gleaned from literature [212]. These values often based on ex-
periments carried out under different conditions or even within different cell
types introduce uncertainties and errors into model predictions. Fortunately
this is an area of active research [13, 213, 214] and new theoretical techniques,
high throughput experimental data and computational power are increasing our1365
ability to infer model parameters from experimental data and therefore develop
more reliable models. But this remains still a formidable challenge where spa-
tial, stochastic and multiscale events are involved. Addressing this requiring not
only new mathematical and computational techniques but a community wide
cross-disciplinary effort to openly share data and protocols so that parameter1370
inference can occur across all scales.
As discussed above, haemostasis is a complex systemic phenomenon based
on a subtle equilibrium between various pro- and antithrombotic factors. Its
malfunctioning can lead to numerous bleeding disorders or thrombotic events
and represents major direct, or indeed indirect, causes of mortality and mor-1375
bidity. One of the most dangerous and common among these is deep venous
thrombosis (DVT), a blood clotting disorder that occurs when excessive blood
clotting occurs inside deep veins. It can provoke embolisms where a part of the
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clot breaks off and subsequently blocks blood circulation in smaller vessels.
The risk factors for developing deep venous thrombosis are numerous and1380
include obesity, cancer, injury and slow blood flow due to the lack of physical
activity. Recurrent thrombi can be prevented by controlling these risk factors or
by the use of anticoagulant drugs. There are several anticoagulant drugs that
target the coagulation cascade at different points. Some new anticoagulants
target single points ,such as factor Xa or thrombin [215]. Others like heparin1385
increase the activity of antithrombin [216]. Another important type of antico-
agulant drugs is vitamin K antagonist (AVK) drugs such as warfarin. It acts
by reducing vitamin K-dependent factors modification in the liver [217]. As a
result, the functionalities of the key blood clotting factors such as prothrombin
and factors IX and X are decreased.1390
Warfarin treatments are monitored by blood tests for the International Nor-
malized Ratio (INR). This is an in vitro assay based on the measurement of the
prothrombin time (PT). This characterizes the time interval necessary to convert
prothrombin into thrombin under specific experimental conditions. Depending
on the measured value of INR, the administrated dose of warfarin is adjusted1395
in order to reach a therapeutic range. In DVT, the targeted level of INR is
between 2.0 and 3.0 [218]. A lower than 2.0 value of INR indicates the predis-
position of the patient to develop recurrent thrombosis while a higher than 3.0
value signifies a high risk of bleeding. The difference between the experimental
settings under which the INR is measured and in vivo physiological conditions1400
can result in cardio-vascular events even for a normal INR level. These tests are
flawed as they do not consider the effect of blood flow and the direct inhibition
of thrombin by antithrombin [110].
One of the main issues in the treatment of thrombosis is the individual
selection of the medication and protocol of its administration on the basis of1405
personalized patient specific data. This is an area where mathematical modeling
can be extremely useful, but at present it is obviously not used enough. This
is due not only to the difficulties in constructing theoretical models but also
because systems available for obtaining and processing individual donor data
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are insufficient.1410
A clinically relevant computer model of thrombosis/hemostasis should not
be a model of just one single process, but rather a family of models. In order to
provide general insights and useful predictions, such an approach should take
into account different thrombosis scenarios (ranging from DVT to microvascular
thrombosis) as well as different bleeding possibilities and therapeutic interven-1415
tions. At some stage, these models could then be incorporated into physiological
models of the circulation system.
In summary, the present state-of-the-art in the field is an extremely inter-
esting one. All though great advances have been made in understanding the
many individual components that lead to thrombosis our current inability to1420
integrate them into a dynamic whole is holding back understanding and the de-
velopment of more effective anti-thrombotic therapies. But, we are experiencing
an unprecedented flow of experimental data, rise in computational power, and
development of new methods that fill us with hope to overcome obstacles. The
mathematical models that we have described show great promise, and by ad-1425
dressing some of the challenges we have described they can come of age. Then,
with a truly cross-disciplinary approach, the ever growing increase in compu-
tational power and availability of high-dimensional experimental and clinical
data we believe these models can play a large role in integrating the story of
thrombus formation into a coherent role.1430
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